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ABSTRACT
FUNCTIONALIZED NANOPARTICLES FOR BIOLOGICAL IMAGING AND
DETECTION APPLICATIONS
February 2009
BING C. MEI, B.A., UNIVERSITY OF PENNSYLVANIA
Ph.D., UNIVERSITY OF MASSACHUSETTS-AMHERST
Directed by: Professor T. J. Mountziaris

Semiconductor quantum dots (QDs) and gold nanoparticles (AuNPs) have gained
tremendous attention in the last decade as a result of their size-dependent spectroscopic
properties. These nanoparticles have been a subject of intense study to bridge the gap
between macroscopic and atomic behavior, as well as to generate new materials for novel
applications in therapeutics, biological sensing, light emitting devices, microelectronics,
lasers, and solar cells. One of the most promising areas for the use of these nanoparticles
is in biotechnology, where their size-dependent optical properties are harnessed for
imaging and sensing applications. However, these nanoparticles, as synthesized, are
often not stable in aqueous media and lack simple and reliable means of covalently
linking to biomolecules. The focus of this work is to advance the progress of these
nanomaterials for biotechnology by synthesizing them, characterizing their optical
properties and rendering them water-soluble and functional while maintaining their
coveted optical properties.

vii

QDs were synthesized by an organometallic chemical procedure that utilizes
coordinating solvents to provide brightly luminescent nanoparticles. The optical
interactions of these QDs were studied as a function of concentration to identify particle
size-dependent optimal concentrations, where scattering and indirection excitation are
minimized and the amount light observed per particle is maximized. Both QDs and
AuNPs were rendered water-soluble and stable in a broad range of biologically relevant
conditions by using a series of ligands composed of dihydrolipoic acid (DHLA) appended
to poly(ethylene glycol) methyl ether. By studying the stability of the surface modified
AuNPs, we revealed some interesting information regarding the role of the surface ligand
on the nanoparticle stability (i.e. solubility in high salt concentration, resistance to
dithiothreitol competition and cyanide decomposition). Furthermore, the nanoparticles
were functionalized using a series of bifunctional ligands that contain a dithiol group
(DHLA) for surface binding, a PEG segment to instill water-solubility and a terminal
functional group for easy bioconjugation (i.e. NH2, COOH, or biotin). Finally, a sensing
application was demonstrated to detect the presence of microbial DNA (unmethlylated
CpG) by using Toll-like receptor 9 proteins as the recognition components and the QDs
as the transduction elements via Förster Resonance Energy Transfer.
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CHAPTER 1

INTRODUCTION TO NANOPARTICLES AND OVERVIEW OF RESEARCH
“There is plenty of room at the bottom”
-Richard Feynman

1.1

Introduction to Nanotechnology
Nanotechnology is the field of science that deals with the control and

manipulation of matter at the length scale between 1-100 nm.1,2 The significance and
impact of such technologies were predicted by Feynman in his talk in 1959 entitled
“There is plenty of room at the bottom.” In his talk, Feynman described some of the
promise of nanotechnology, going as far as the possibility of assembling molecules one
atom at a time! Half a decade later, tremendous progress has been made but we have
merely scratched the surface of the possibilities; the two challenges he posed in his talk,
building a mini motor that fits into a 6x10-11 m3 cube and writing the contents of a book
in 1/25,000 scale, were completed by 1985. Today, the potential of nanotechnology has
been recognized by researchers and funding agencies around the world (Figure 1.1),
leading to establishment of programs and institutes, such as the National Nanotechnology
Initiative (NNI) and International Institute for Nanotechnolgy (IIN), that are making the
exploration of the nano-world a top priority. Some may argue that nanotechnology is
merely a trend, but it is indisputable that nanotechnology can (and have) produce new
materials and novel applications as evident from many of the already commercial
products.3
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While nanotechnology offers new tools for assembling materials, many of the
exciting new properties or physical phenomena in the nano-scale arise due three major
size-related reasons: large surface to volume ratio, quantum confinement and a change of
the force/energy landscape with the shrinking scale. First, as a material’s size is reduced,
its surface to volume ratio increases dramatically (i.e. a large fraction of its atoms will
reside on its surface), so its behavior is dominated by its surface atoms and their
interaction with their surrounding. Second, as the size of the material is reduced beyond
a critical threshold (often in the nano-scale), the atoms’ electrons become confined or
squeezed by the physical dimensions resulting in new mechanical, optical, electronic, and
magnetic properties not observed for bulk materials; this is known as quantum
confinement or quantum size effect. Also due to the change in size scale, the dominating
forces will also shift in significance, as recognized by Feynman in 1959. For example,
while gravity keeps us (macroscopic objects) grounded, at the nano-scale, gravity will no
longer be the dominating force. Instead, other forces such as van der Waals,
electrostatics and surface tension will prevail. Sometimes this change in force or energy
landscape will instill novel properties, while at other times, it will become a challenge
that needs to be overcome.
One of the most actively studied and promising areas of nanotechnology is in the
area of clusters or nanoparticles, where the particle consists of 102 to 107 of atoms (1 –
100 nm).4 These nanoparticles exhibit behaviors that are both bulk- and atomic-like,
owing to quantum-mechanical rules, and are therefore sometimes referred to as “artificial
atoms.” The properties of the nanoparticles are determined by the material’s
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composition, size, shape, inter-particle distances and the protecting organic layer. Two of
such examples, which are the focus of study in this dissertation, are quantum dots (QDs)
and gold nanoparticles (AuNPs).5,6

1.2

Properties and Advantages of Quantum Dots
Quantum dots (QDs) are semiconductor nanocrystals with diameters less than the

average separation of an electron-hole pair, also known as the Bohr exciton.7 When bulk
semiconductors are reduced in size below the Bohr exciton radius, they experience
quantum confinement, which is manifest in its density of states. As the dimensionality is
reduced from 3-D (bulk material) to 0-D (QD), where the material is confined in all three
dimensions (x, y, z), the density of states of the material evolves from having continuous
levels to having discrete states (Figure 1.2). Due to the confinement of the electron-hole
pair by the grain boundary, QDs exhibit size-dependent bandgap energy as predicted by
quantum mechanics.8,9 Due to their unique properties, QDs have potential applications in
many disparate fields, such as biological sensing, light emitting or display devices,
microelectronics, lasers, and solar cells. The most promising application is in the field of
clinical diagnostics, where they can be used as luminescent tags for biomolecules or
further developed into biosensor. 5,10-13 These luminescent nanoparticles offer a number
of valuable properties including: 1) biologically relevant particle size, 2) size-tunable
photoluminescence emission that is narrow and symmetric, 3) broad absorption spectra
that spans wavelengths smaller than its emission into the UV region, 4) resistance to both
photo and chemical degradation, and 5) high extinction coefficient and quantum
yield.11,14 These properties are further discussed below.
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The excitement in nanotechnology is, for the most part due to dimension, so it is
no surprise that one of the key advantages of QDs (and other nanoparticles) for biological
applications is their size. QDs are an order of magnitude larger than conventional
organic dyes, but are similar in size compared to moderately-sized proteins (Figure 1.3).
The redder QDs (given same chemical composition) tend to be slightly larger in size.
While the larger size (compared to organic dyes) can become a liability in some
applications, it can be a key advantage for others, such as sensing. Being larger than
proteins, each QD can accommodate multiple proteins (of the same or different species)
or other chemical moieties. Adsorbing multiple copies of the same molecule can
decrease the limit of detection, while attaching multiple chemical moieties per QD allows
multi-functionality (each moiety imparting a unique function) or the ability to
multiplex.14
The size-tunable absorption and emission of QDs are probably the most
interesting properties for researchers because they provide a way to manufacture
luminescent tags of different colors; by simply changing the nanocrystal size (or shape)
as shown in Figure 1.4A. This is also one of the key advantages of QDs over organic
fluorophores, because organic dyes of varying colors require different synthesis. Not
only can the design and synthesis of new organic dyes be challenging and time
consuming, the resulting organic molecules that emit different colors will have varied
chemical structures and may respond to environmental changes (i.e. pH, temperature,
solvent, etc) in very different ways, making it difficult to use multiple dyes in the same
environment. However, QDs are relatively insensitive to environmental changes, and
even if there are media effects, different color QDs should respond in the same way since
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their chemical composition is identical. Furthermore, their emission spectra are narrow
(~30 nm FWHM) and symmetric, while their absorption spectra are broad (Figure 1.4B).
Due to the narrow and symmetric emission spectra compared to organic dyes, multiple
QD samples can be viewed within one spectral window of a single organic fluorophore;
Figure 1.4B shows the emission spectra of 4 species of QDs in the spectra window of one
organic fluorophore, Cy3. Since QDs can be excited by any wavelength smaller than the
emission wavelength, a single UV excitation source (i.e. ~350 nm) can be used to excite
all the QD samples shown in Figure 1.4. Such optical properties allow researchers to
create QD populations that enable multiplexing (i.e. ability to visualize multiple species
using one excitation wavelength without substantial signal cross-talk).
The photochemical stability of QDs is yet another major advantage over
conventional organic fluorophores. As mentioned above, organic fluorophores may be
very sensitive to the local environment in which it operates, for example fluorescein is
very sensitive to pH. While this properties can be harnessed sometimes (fluorescein can
be used to detect changes in pH),15 the environment sensitivity of organic dyes is often a
liability. Wu et. al. demonstrated the photostablity of red CdSe/ZnS QDs (630 nm
emitting) compared to Alexa 488, which is a commonly used green dye (Figure 1.5).16
On the top strip of images, the microtubles of a 3T3 fibroblast cell were labeled with
Alexa488 conjugated with anti-mouse IgG (green), while the nuclear antigens were
labeled with QDs (red). On the bottom strip of images, the microtubles were labeled with
QDs while the nucleus was stained with Alexa 488. The cells were continuously
illuminated for 3 minutes, and the QDs were clearly much more photo-stable, while the
organic fluorophores were quickly photobleached even in the presence of an anti-fading
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agent. QDs, being more resistant to photo and chemical degradation, allow researchers to
visualize and track cells for a longer period of time, or enable sensors that can operate in
a broad range of conditions.14,16,17 In addition, QDs also have high quantum yields as
well as high extinction coefficients compared to most organic dyes, which translates to
bright emission, and easily detectable absorbance.

1.3

Properties and Advantages of Gold Nanoparticles
Gold nanoparticles or colloidal gold can be dated back as far as the 5th century

B.C., when they were used for their aesthetic properties in the production of stained
glass; colloidal gold is bright red if the nanoparticles are smaller than ca. 100 nm. People
have also explored the used of “drinkable” gold for its presumed curative properties in
the Middle Ages.18 The first modern science account of gold nanoparticles was by
Faraday, in 1875, when he recognized that the bright red color from gold solutions was
due to small gold particles. However, interest in gold nanoparticles was low until the late
1990’s; there were less than 100 papers published about “gold nanoparticles” from 19901995 and ~3400 published papers on the topic in 2007 alone (Web of Science). The
recent increase in attention to gold nanoparticles, like QDs, is due to their size-dependent
physical and chemical properties that make them useful for many applications, especially
in biology.18 AuNPs can be classified into three categories according to their size: large
nanoparticles (R>λ of external electromagnetic fields), small nanoparticles (ca. 1-50 nm),
and clusters (< ca. 0.5 nm).19 The optical properties of the large nanoparticles depend on
their bulk-like dielectric function relative to the surrounding medium and they can be
quantitatively described by Mie theory.20 The size of the second category of gold

6

nanoparticles approaches the electron mean free path (~50 nm), so their refractive index
and dielectric function are strongly dependent on the particle-size (Figure 1.6). In the
third category, the gold clusters reach another length scale, which is defined by the de
Broglie wavelength of the valence electrons (~0.5 nm). In this smallest length scale, gold
nanoparticles become quantum dots (0-D) and can fluoresce like semiconductor QDs.
These gold clusters are difficult to synthesize and is a topic of study by itself.19 Our
attention in this work is focused on the second category, the small gold nanoparticles
(Figure 1.6), which will be referred to as AuNPs in the rest of this document. AuNPs
have a unique set of optical properties that make them attractive for applications
including imaging, thermal therapeutics, drug delivery as well as sensing and detection.
AuNPs strongly interact with radiation such as visible light, electrons and x-ray
waves, which make them attractive candidates for contrast agents in a variety of imaging
techniques.21-23 Gold nanoparticles strongly absorb as well as scatter visible light.
AuNPs > 20 nm can be imaged with optical microscopy using phase contrast or
differential interference contrast (DIC) modes as they scatter light strongly. Their
absorption of light results in the collective oscillation of their free electrons, which gives
rise to the surface plasmon resonance band (SPB) or a strong absorption ca. 510-530 nm
for AuNPs of 4-40 nm in size.23

Furthermore, these metallic nanoparticles can be used

as contrast agents in x-ray and transmission electron microscopy (TEM) imaging because
they provide high contrast due to their strong interactions with both forms of waves (xray and electrons).
Due to their size-tunability, inertness and facile surface for chemistry, AuNPs are
being researched for drug delivery and other therapeutic purposes.21,24 One such example
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is the use of AuNPs to deliver tumor necrosis factor (TNF) or other drugs to tumor tissue
via the enhanced permeability and retention (EPR) effect; nanoparticles can effectively
permeate and collect at tumor cells, resulting in favorable bio-distribution, due to a
combination of size (of AuNPs and pores in tumor blood vessels) and architecture of the
tumor vasculature, which lacks effective lymphatic drainage (Figure 1.7).24-26 As a result,
drugs attached to the nanoparticles can selectively collect at the tumor site where they are
retained for an extended period of time as the drugs are released. A more exotic
therapeutic use of AuNPs is in photothermal therapy, where the AuNPs’ large absorption
cross section around their surface plasmon band is harnessed to absorb light and release
heat rapidly (in picosecond time frames) to either kill sounding cell (i.e. tumors) or
release a drug pay-load wrapped in a heat sensitive material (Figure 1.8).23,27 For
example, 40 nm AuNPs have a molar extinction coefficient of ~8x109 M-1 cm-1 as
compared to ~104 M-1 cm-1 for indocyanine green, a common organic dye used in
photothermal tumor theraphy.28 For this form of therapy, however, it is desirable to have
the SPB band in the near-infared region (NIR radiation can penetrate tissue), which can
be accessed by changing the nanoparticles’ shape; gold nano-rods can have SPB from
500 – 800 nm.
As is the case for semiconductor QDs, AuNPs are heavily studied for biosensing
applications due to their small size (large surface area), and unique photophysical
properties. The emerging biosensing schemes include colorimetric detection of solution
phase aggregation,29 resonant light scattering (or other transduction methods) of gold
stained surfaces30 and quenching of fluorescence due to the presence of AuNPs.31
Several examples are shown in Figure 1.9, with a brief explanation in the caption.
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Additional details can be found in the suggested references for the interested reader.
Other transduction methods, including the use of surface enhanced Raman scattering and
electrochemical measurements, are also detailed in various review articles.23,32

1.4

Overview of Research
While QDs and AuNPs exhibit properties that are of great interest in biology and

nanotechnology as described above and in the related literature, these inorganic
nanoparticles “as-synthesized” are often not water-soluble and/or unstable under typical
biological conditions.13,18 The further development of nanoparticles (QDs and AuNPs,
alike) for biological applications is hampered by the lack of simple and reliable methods
for creating stable and versatile inorganic-biomolecule hybrid conjugates. The purpose
of this research is to push the frontier of applications of these nanoparticles in the area of
biological imaging and detection by addressing this vital issue. This effort consists of
several major parts:
1)

CdSe and ZnSe-based QDs were synthesized to provide fluorophores emitting in
the visible region of the electromagnetic spectrum; ZnSe QDs emit in the UV –
blue region and CdSe QDs in the blue into the red wavelengths (Chapter 2).
While gold nanoparticles can also be synthesized, their synthetic methods are well
established and AuNPs can be purchased from reliable commercial sources. For
this reason all gold nanoparticles used in this work were purchased from Ted
Pella, Inc.

2)

The optical properties of the QDs were studied as a function of dilution, which
offers insights into the optical interactions that occur between the radiation and
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the nanoparticles as well as inter-particle interactions in a QD dispersion.33 These
results are significant for achieving the maximum signal from QDs used in
imaging and sensing (Chapter 3).
3)

A series of neutral (or inert) modular bidentate poly(ethylene glycol) ligands were
synthesized to stabilize and functionalize the nanoparticles, rendering them watersoluble.17,34 The utility of the ligands were demonstrated by preparing watersoluble and stable QDs and AuNPs (Chapter 4).

4)

While the ligands synthesized in chapter 4 can render AuNPs water-soluble and
stable in high ionic strength and broad pH, it is unclear whether the bidentate
ligand offers advantages over the monodentate analogue. A mono-thiol PEG
ligand of the same composition as the bidentate one (besides a different binding
group) was synthesized and its applications to AuNPs were compared on the basis
of the colloidal and chemical stability of the resulting nanoparticles. This study
elucidates the role of the binding group as well as the ligand’s chemical structure
on the stability of the nanoparticles (Chapter 5).

5)

Additional ligands were synthesized to create water-soluble nanoparticles that
can be linked to biomolecules via covalent bonds. These functionalized
nanoparticles are often referred to as “biocompatible”, because they facilitate easy
conjugation to biomolecules, but this does not necessarily mean they are nontoxic
as the term implies in the medical field. Functionalized nanoparticles were
prepared using new ligands and conjugation to organic molecules was
demonstrated.35 Furthermore, these multifunctional ligands were used to
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determine the number of available surface binding sites on the surface of a single
QD (Chapter 6).
6)

While Chapter 6 describes the techniques employed for covalently linking
molecules to the inorganic nanoparticles, we also demonstrate bioconjugation
using histidine metal chelation to attach proteins to the surface of QDs. Using
these QD bioconjugates, we show a proof-of-concept experiment of a Förster
resonance energy transfer (FRET)-based biosensor that can be used to detect the
activity of Toll-like receptors (Chapter 7).
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Figure 1.1: Plot showing the increasing international investment in nanotechnology.
Figure adapted from reference 3.
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Figure 1.2: The density of states versus energy of a semiconductor materials changes as
it is reduced from a 3D to a 0D structure.
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Figure 1.3: Relative size of 550 nm emitting CdSe/ZnS core/shell QDs (~ 6 nm)
compared to maltose binding protein (MBP) and green fluorescent protein (GFP). Figure
adapted from reference 14.
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Figure 1.4: Images and optical spectra of QD dispersions. A) Photograph of QDs in
hexane illuminated by white light (incandescent, top) and a hand held UV lamp (~365
nm, bottom). The QD dispersions are approximately 0.5 M in concentration. Vial (1)
contains ZnSe QDs of ca. 3.0 nm, (2 – 4) contains CdSe/ZnS core/shell QDs with a core
diameter of 3.2, 4.0 and 4.9 nm, respectively. The CdSe/ZnS QDs contain ~3-5
monolayers of ZnS overcoating on top of the CdSe core. B) Photoluminescence (PL) and
absorption spectra of CdSe/ZnS QDs and Cy3, showing that 4 different QDs (of different
emission) can be placed in the spectra window of Cy3, a common organic dye. The plot
also shows that QDs have broad absorption spectra (Figure B adapted from reference 14).
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Wu et al. Nature Biotech 21, 41-46 (2003)

Figure 1.5: Demonstration of the photo/chemical stability of QDs compared to
Alexa488, a common organic fluorophore. Top, 3T3 cell whose nuclear antigens were
labeled with 630 nm emitting CdSe/ZnS QDs conjugated with streptavidin and the
microtubules were labeled with Alexa488 conjugated with anti-mouse IgG (green). In
the bottom sequence, the tags were reversed. The cells are continuously illuminated by a
100 W mercury lap using a 100x oil immersion lens and the emission intensity was
measured producing the data shown in the plot. (Figure adapted from reference 16)

Figure 1.6: Images of gold nanoparticle dispersions from 2-200 nm in size, which results
in different colors of their solutions ranging from clear to red to violet. Image from
tedpella.com (Ted Pella, Inc.).
14
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Figure 1.7: Illustration of the EPR effect,25 where drug-loaded nanoparticles can be
passively targeted to tumor tissue. Such products are already in clinical studies for FDA
approval (see CytImmune.com).

b)

Figure 1.8: Illustration of the concept of photothermal therapy, where the AuNPs can be
used to kill cells by heat (a), or the heat can release drugs embedded in a heat sensitive
polymer (b). Adapted from reference 23.
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a)

b)

c)
QD

QD

Figure 1.9: Examples of sensing schemes that use the unique photophysical properties
of AuNPs. (a) Analytes can be detected by the aggregation of AuNPs, which leads to a
change in color as the surface plasmon resonance is affected by the neighboring particles.
This was first demonstrated by Mirkin et al for DNA,29 and later has been extended to
various targets.36,37 (b) The AuNPs can also be used in a sandwich assay format
(analogous to an enzyme linked immunosorbent assay or ELISA), the functionalized
particles only bind to the surface in the presence of the target analyte.30 The sensitivity of
this assay can be enhanced by depositing silver onto the surface bound AuNPs.38 (c) A
target analyte can also be detected by measuring the increase in fluorescence when the
analyte frees the AuNPs from the tethered fluorophore; gold nanoparticles can quench the
fluorescence emission of a dye (or as shown in the figure, a QD) if it is in close proximity
due to a dipole-metal interaction.31
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CHAPTER 2

SYNTHESIS AND CHARACTERIZATION OF QUANTUM DOTS

2.1

Introduction
There has been a variety of techniques reported for the synthesis of quantum dots

(QD). The many synthetic methods include arrested nucleation,1 injection of
organometallic precursors into hot coordinating solvents,2 chemical bath synthesis in the
presence of a polymer capping agent,3 vapor-phase synthesis,4 and synthesis using
templates formed by reverse micelles,5 microemulsions,6 or liquid crystals.7,8 While the
area of QD synthesis is active, the highest quality of nanocrystals (i.e. high quantum
yield, narrow size distribution) are those made by organometallic synthesis in hot
coordinating solvents performed in small stirred batch reactors. For this reason, all the
QDs used in this thesis, unless otherwise stated, are produced by this synthetic method.
In this chapter, the synthesis and characterization of the QDs used throughout this
dissertation will be presented. Also presented here are some important characterization
techniques for studying the properties of quantum dots, as well as novel methods for
determining the particle size of ZnSe QDs.

2.2

Experimental Methods and Procedures
The detailed synthetic methods of ZnSe core and ZnSe/ZnS core/shell QDs are

presented in this section. However, since the synthesis of CdSe-based QDs are well
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established and not the focus of this work, only a brief description is provided for
completeness. The interested reader is directed to references for more details. 9-12

2.2.1

Organometallic Synthesis of Quantum Dots
All the organometallic synthetic steps were performed under nitrogen protection

to prevent the materials and precursors from oxidation. A schematic of the experimental
setup is shown in Figure 2.1.
Synthesis of ZnSe QDs: ZnSe QDs were synthesized using the hot injection of
organometallic precursors into a coordinating solvent.2,9 In a 100 mL 3-neck round
bottom flask, hexadecylamine (HDA, 14 g, 5.8x10-2 mol) was melted , brought to 100°C,
degassed in vacuo for at least 1 h (to remove water and low boiling point impurities) and
purged with N2. Selenium powder (-100 mesh, 8.7x10-2 g, 1.1x10-3 mol) and
trioctylphosphine (TOP, 1 mL) were placed into a 20 mL scintillation vial, sealed with a
septum and purged with N2. The selenium-TOP mixture was heated at ~60 °C until a
homogeneous solution was obtained and allowed to return to ambient temperature. Then
diethylzinc (0.9 mL, 1 M solution in heptane, 9.0x10-4 mol) was added to the scintillation
vial, forming the precursor mixture, and diluted with TOP (4 mL). The degassed HDA,
under constant vigorous stirring, was then heated to 315 °C and the precursor was swiftly
injected into the hot coordinating solvent in one continuous motion. The reaction was
quickly cooled to ~230 °C and then returned to 275 °C to allow the ZnSe nanocrystals to
grow. Samples were extracted at increasing reaction times to obtain ZnSe QDs that
increase in particle size; ~0.1 mL aliquots were extracted and dispersed in 2 mL butanol
to monitor the growth process via UV-Vis absorption or fluorescence spectroscopies.
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When the QDs reached the desirable size, the reactions was cooled to ~60 °C, which
stops the nanocrystals from further increasing in size, and the samples were transferred to
scintillation vials for storage in a dark place (or wrapped with aluminum foil) without
further cleaning. Since HDA (the major component of the as-synthesized QDs) is solid at
room temperature, the sample should be transferred for storage while it is still warm. The
synthesis of larger ZnSe QDs (> 3.5 nm) were also attempted by injecting more
precursor, prepared in the same way as described above, at different reaction times.
Synthesis of ZnSe/ZnS core/shell QDs: ZnSe/ZnS core/shell nanostructures
were synthesized by overcoating the ZnSe core with additional layers of ZnS.13
Trioctylphosphine oxide (TOPO, 7.5 g) and HDA (3.8 g) were placed into a 100 mL 3neck flask, heated to 100 °C, degassed in vacuo for at least 1 h (to remove water and low
boiling point impurities) and purged with N2. TOP (0.5 mL) was injected into the flask
and the temperature was reduced to 65 °C. Then as-synthesized ZnSe QDs (3 mL ZnSe
QDs, diluted in 3 mL of hexane) were injected into the reaction flask. The hexane was
evaporated in vacuo, and the reaction mixture was again purged with N2. A ZnS
precursor was prepared by adding bis(trimethylsilyl)sulfide ((TMS)2S, 22 uL, 1.04x10-4),
diethylzinc (0.1 mL, 1 M solution in heptane, 1.0x10-4 mol), and TOP (3 mL) into a 20
mL scintillation vial under nitrogen protection. The reaction flask was then heated to the
desired temperature, which is QD size-dependent; for ZnSe of 7-8 nm and 2-3 nm, the
optimal injection temperature should be ~250 °C and 235 °C, respectively. The
precursor was then injected into the reaction flask (0.5 mL every 2 min) while the
mixture was vigorously stirred. Once the injection of the ZnS precursor was complete,
the temperature was reduced to ~95 °C, at which the ZnSe/ZnS QDs were left to anneal
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for 3 hours. Following the reaction, the temperature was reduced to ~60 °C and the
ZnSe/ZnS core/shell QDs were transferred into scintillation vials for storage without
addition cleaning.
Synthesis of CdSe and CdSe/ZnS core/shell QDs: The CdSe QDs were
synthesized using a similar method as described above and detailed procedures can be
found in literature.9-12 While the general procedure is similar, the reaction temperatures,
organometallic precursor and coordinating solvent used are different from that which was
used for ZnSe QDs. For CdSe core growth, a mixture of TOP, TOPO, and HDA were
used as the coordinating solvent. Selenium and cadmium acetylacetonate in TOP was
used as the precursor.
After growing the CdSe core, excess unreacted metals were removed by several
cleaning steps and several monolayers of ZnS were grown around the CdSe core to make
CdSe/ZnS core/shell nanocrystals. The overcoating with the ZnS layers was carried out
using the same high temperature reaction scheme but at a slightly lower temperature than
the one used for the core growth. The precursor used for the ZnS overcoating composed
of bis(trimethylsilyl)sulfide ((TMS)2S) and diethylzinc in TOP. Detailed description of
the synthesis can be found in previous reports.10,12,13

2.2.2

UV-vis Absorption and Photoluminescence Spectroscopy
When appropriate, the QD samples were characterized by UV-vis absorption and

photoluminescence spectroscopy. The UV-vis experiments were performed in various
solvents using a HP 8453 diode array spectrophotometer (Agilent technologies, Santa
Clara, CA) with proper background corrections. Photoluminescence experiments were
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performed on multiple instruments, including: SPEX Flurolog-2 Spectrophotometer
(Jobin Yvon Inc., Edison, NJ) and SpectraMax Gemini XS Microplate
Spectrofluorometer (Molecular Devices Corporation, Sunnyvale, CA). The excitation
wavelength and instrument used is recorded with the data.
Excitation experiments were also conducted, where the PL emission was detected
at a fixed wavelength (at the emission maximum) while the excitation wavelength was
varied.

2.2.3

Quantum Yield Measurements
Relative quantum yield measurements of QDs were performed according to

established procedures and calculated using Equation (2.1).14

Ar Ix n x 2
Φx = Φr
A x Ir n r 2

(2.1)

where Ф is the quantum yield, A is the absorbance at the excitation wavelength, I is the
integrated PL intensity, and n is the solvent refractive index. The subscripts r and x
denote the reference fluorophore of known quantum yield and sample, respectively.
When measuring the QY of ZnSe, anthracene15 in ethanol and aminopyridine16 in 0.1 M
H2SO4 were used as reference fluorophores, while rhodamine-6G17 in ethanol was used to
measure CdSe and CdSe/ZnS QDs.
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2.3

Results and Discussion

2.3.1

Quantum Dot Synthesis
Injection of organometallic precursors into hot coordinating solvents is among the

most established method of producing high quality QDs. While the method is well
documented in literature, the ability to synthesize high quality nanocrystals is still often
referred to as an “art” within the quantum dot scientific community. Three key issues
must be considered when preparing brightly luminescent QDs with narrow size
distribution. 1) Care must be taken to ensure that all the steps of the reaction are
preformed in an inert environment and with fresh materials that were properly stored. 2)
The precursor for core growth needs to be injected swiftly at the correct injection
temperature (~315 °C for ZnSe QDs) in order to minimize the particle size distribution.
3) Following precursor injection, the reaction mixture must be rapidly cooled below the
core growth temperature in order to stop nucleation and then gradually heated to the
growth temperature (275°C for ZnSe). The successful implementation of these three
points should result in QDs with narrow size distribution as predicted by models.18,19
Samples can be extracted at increasing reaction time to monitor the growth process. The
QDs extracted after longer reaction times should show a red shift in the PL emission as
shown in Figure 2.2, because the QDs are growing in size. The PL intensity should also
increase due to better crystallinity of the nanocrystals with longer reaction (or annealing)
times.
Larger QDs can be synthesized by injecting more precursor during the core
growth phase of the reaction. This is demonstrated in Figure 2.3, which plots the peak
PL wavelength versus reaction time. Also shown in the plot is the size of the
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nanocrystals as determined by the method presented in Section 2.3.2. As shown in
Figure 2.3, the size of the ZnSe QDs was approaching a plateau after ~30 min of the core
growth reaction following the initial injection of the precursor solution. At t = 45 and 60
min, 1 mL of precursor solution was added per interval, which fueled the growth of the
nanocrystals. Finally at t = 76 min, 2 mL of precursor solution was added. However, the
size increase per volume of precursor was reduced; from 40 min to 75 min the
nanocrystals grew ~0.8 nm, but from 76 min to 120 min the nanocrystals only grew 0.2
nm in diameter. If the volume of the nanocrystals was considered instead (calculated
based on particle diameter), the first 2 mL of precursor resulted in ~18 nm3 of volume
increase, while the last injection of 2 mL of precursor only resulted in ~6 nm3 of volume
increase of the nanocrystals. This may be due to a reduction in reactivity of the
nanocrystals as the particle size increased, which is consistent with what is reported in the
literature.18-20

2.3.2

UV-Vis Absorption and Photoluminescence Spectroscopy
The size-dependent spectroscopic properties of QDs are among their key

attributes that make them interesting for research and applications as discussed in Chapter
1. Figure 2.4 shows the absorption, excitation, and emission spectra of a CdSe/ZnS core
shell QDs as an example of their spectroscopic properties. The absorption spectrum of a
QD sample is characterized by the well defined first exciton, which is the absorption peak
of the lowest energy (or high wavelength, in this example it appears at 536 nm). The first
exciton peak will shift to lower energy (or longer wavelength) as the nanoparticle grows
in size. When the QD is excited in any wavelength where there is sufficient absorption, it
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will emit light at a wavelength which is red-shifted from the first exciton peak (550 nm
for this example). When excited at different wavelengths (given constant light intensity),
the emission intensity will change with the same trends of the absorption spectrum, as
illustrated by the excitation spectrum (maroon line).

2.3.3

Core versus Core/shell Quantum Dots
As reported in literature, overcoating core nanoparticles with a higher bandgap

material can enhance the photoluminescence emission of the resulting core/shell QD with
orders of magnitude increase in quantum yield in organic solvents at room temperature.13
This is generally understood as a reduction in the gap surface states (or surface
“imperfections”) due to surface nonstoichiometry, and unsaturated bonds that promote
nonradiative recombination.10,13 The wider band gap shell also better confines the holes
and electrons within the core. These two points are illustrated in Figure 2.5, which show
the emission spectra of as-synthesized core and core/shell QDs dispersed in an organic
solvent. The broad tail of the CdSe core QDs (700-800 nm) is attributed to the surface
traps, which is reduced in the core/shell sample.9,13 The emission spectra of the core/shell
QDs is also ~6x higher than the plain core nanocrystals.
The enhance PL emission of the QDs is especially significant when the
nanocrystals are transferred into aqueous solutions (e.g. following cap exchange with
DHLA-PEG750-OCH3 ligands, which is detailed in Chapter 4). This is demonstrated in
Figure 2.6, which shows the absorption spectra of QDs before and after overcoating as
well as the emission of the cap-exchanged QDs in water. These particular CdSe/ZnS
core/shell QDs were overcoated with ~3-5 monolayers of ZnS. As the data shows, the
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absorption peak is red-shifted by ~20 nm, which is also seen in the emission data. The
inset of Figure 2.6 shows the emission spectra of the QDs (core and core/shell)
normalized by concentration. This demonstrates that the cap-exchange core nanoparticle
show no emission, while the water-soluble CdSe/ZnS core/shell nanocrystals are brightly
luminescent. The retained PL emission is attributed to better passivation of the QDs by
the higher band gap overcoating material.13,21 For this reason, all the QDs used in
biological applications, which often require water-solubility, are core/shell nanostructures
rather than plain core nanocrystals.

2.3.4

Determining ZnSe QD Size by Photoluminescence Spectroscopy
The band-gap energy of a QD can be expressed as a function of its size using

fundamental equations.22,23 A commonly used equation has been proposed by Brus23:

E ( r ) = Eg +

1 
h2  1
e2
1.786
+
−
+ S (r )


8r 2  me* mh* 
4πεε 0 r

(2.2)

In Equation (2.2), E is the band gap energy of the QD (eV), Eg is the band gap of the bulk
material (eV), h is Planck’s constant, me* and mh* are the effective masses of the electron
and the hole, respectively, e is the electron charge, ε is the relative dielectric constant of
the semiconductor, ε0 is the permittivity of vacuum, and r is the radius of the QD (m).
S(r) accounts for the spatial correlation between electrons and holes and is generally
small;23,24 for this reason it was neglected in our calculations. The Brus equation
provides a reasonable model for estimating the band gap energy variation as function of
QD size and is more accurate for QDs larger than several nanometers.24
Plotted in Figure 2.7 are literature data on the peak PL emission wavelength, λ, of
ZnSe QDs as a function of their average size determined by TEM.2,25-27 Also shown in
29

the plot is the predicted absorption wavelength, hc/E(r), by using Equation (2.2) and the
following parameters for ZnSe: Eg = 2.7 eV, me* = 0.21 electron masses, mh* = 0.6
electron masses and ε = 9.1.28 The deviation between the predictions of Eq. (2.2) and the
PL emission data can be attributed to the Stokes shift between the absorption and
emission wavelengths. The experimental PL emission data can be fitted by an empirical
correlation that links λ with the QD diameter, d:

λg - λ
d
= C ln  c 
λg
d 

(2.3)

In Equation (2.3), λg is the band gap emission wavelength from bulk ZnSe (λg = 460 nm),
dc is the quantum confinement threshold for ZnSe (dc = 9 nm), and C is an empirical
unitless constant whose value was estimated to be 0.128. This empirical relationship
enables one to estimate the average size of a ZnSe QD sample by a simple
photoluminescence experiment, which is a convenient alternative to TEM.

2.3.5

Determining CdSe QD Size by UV-Vis Absorption Spectroscopy

The size of CdSe can also be determined based on an empirical correlation of
spectroscopic data which can be found in literature. The data used in the empirical fit is
reported in reference 10, and plotted in Figure 2.8 as CdSe QD radius versus the
wavelength of the first exciton. Equation (2.4) is the empirical correlation of this data,
which is also shown in the plot as a solid line. Here the rCdSe (nm) is the QD radius, and
the λEx (nm) is the first exciton wavelength (i.e. lowest energy absorption peak).
-5

rCdSe =1.52 + 4×10 e
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λ Ex
59.19

(2.4)

While this correlation provides the means to determine the size of CdSe core QDs, it does
not allow for the calculation of the size of core/shell nanoparticles. To estimate the size
of core/shell particles, it is assumed that the overcoating reaction is quantitative (i.e.
complete reaction of all the ZnS precursor). Based on the concentration and average
particle size of the CdSe QDs used in the overcoating reaction, the average number of
layers of ZnS overcoating can be calculated. The average radius of the CdSe/ZnS core
QD, rCdSe/ZnS (nm), is then calculated using Equation (2.5), where N is the number of
monolayers and MLZnS is the monolayer thickness, which is assumed to be 0.31 nm (half
of the c parameter in bulk wurtzite ZnS).29

rCdSe/ZnS = rCdSe + N× ML ZnS

2.3.6

(2.5)

Extinction Coefficient of Quantum Dots

Prior to applying the QDs, one needs to determine the extinction coefficient of the
nanoparticles in order to quantify them. There are a couple of reported methods of
determining the extinction coefficient, ε, of CdSe quantum dots.30,31 The approach that
was used for the work presented in this thesis is the method reported by Leatherdale et
al.30 In this approach, the authors determined the size correlation to the extinction
coefficient at 350 nm as shown in Equation 2.6, where r (cm) is the QD radius.

ε ( M -1cm -1 ) = 1.438 × 10 26 r 3

(2.6)

It is assumed that the extinction coefficient of a QD before and after overcoating
is the same. While this assumption contains an error, which is larger for smaller core
nanoparticles with several overcoating layers, it is the best approximation available to
quantify the quantum dot concentration. However, the error is relatively small if it is
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applied to larger cores as the ZnS contribution becomes smaller.10 There is not yet a
published method for determining the extinction coefficient of ZnSe QDs. All
concentrations of ZnSe QDs are calculated by using Equation (2.3) to determine the
average particle size and assuming that all the raw materials (or the limiting reagent,
which is usually diethyl zinc for the experiments reported here) are consumed in the
reaction. Therefore, the concentration quantification of QDs (CdSe/ZnS, ZnSe, and
ZnSe/ZnS) is an excellent topic for a future thesis project, which will certainly make a
dramatic impact in the field of QD research.

2.4

Conclusion

In this chapter, the organometallic synthesis of ZnSe, ZnSe/ZnS, CdSe and
CdSe/ZnS core and core/shell QDs was presented. The inorganic synthesis of QDs is an
active area of research, but the methods presented are well documented in literature and
nanocrystals synthesis is routine in both the Mountziaris (UMass) and Mattoussi (NRL)
laboratories. More importantly, this chapter also presents some essential characterization
techniques which are frequently used throughout this dissertation. These include
experimental techniques such as UV-Vis and photoluminescence spectroscopy as well as
analytical calculations for determining the average size and extinction coefficient of the
QDs.
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ZnSe QDs. I am also grateful to Dr. Hedi Mattoussi for his tutelage, helpful discussions
and gift of the CdSe and CdSe/ZnS samples used in this thesis.
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Figure 2.1: Schematic of the batch reactor system used for QD synthesis.27
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Figure 2.2: Photoluminescence spectra of ZnSe QDs extracted at increasing reaction
times. 5 min (diamonds), 10 min (squares), 20 min (triangles) and 30 min (circles) min.
The PL emission was measured using the SpectraMax Gemini XS Microplate
Spectrofluorometer.
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Figure 2.4: Absorption and excitation spectra of as-synthesized CdSe/ZnS core/shell
QDs in hexane. Both the spectra are normalized by its value at 536 nm, which is also the
position of the first exciton peak. The inset shows the emission of the QD, which has a
peak at 550 nm.
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Figure 2.5: PL spectra of CdSe (dotted line) and CdSe/ZnS core/shell (solid line) QDs
normalized by the absorption at the excitation wavelength (470 nm). It shows that the
core/shell QDs have 6x the emission intensity while showing reduced red-tailing, which
is attributed to surface trapped states. Figure adapted from ref. 13.
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Figure 2.6: Absorption spectra of CdSe core (blue, squares) and CdSe/ZnS core/shell
(circle, maroon) QDs. The absorption spectra are normalized by the first exciton peak;
514 nm for core and 532 nm for core/shell QDs, respectively. The inset shows the
emission spectra of water-soluble CdSe core (blue, squares) and CdSe/ZnS core/shell
(circle, maroon) QDs, where the emission is normalized by the QD concentration.
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Figure 2.7. Dependence of PL emission wavelength on QD diameter of ZnSe. Data
from: (•) this work; (∆) Ref. 2; (◊) Ref. 25; (□) Ref. 26; ( ) Ref. 27. The solid curve is
the predicted absorbance wavelength according to Eq. 2.2 and the dashed curve is an
empirical fit to the emission wavelength according to Eq. 2.3.
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CHAPTER 3

DILUTION EFFECTS ON THE PHOTOLUMINESCENCE OF
QUANTUM DOT DISPERSIONS

3.1

Introduction

Due to their excellent photochemical stability, spectroscopic properties and small
size, there is tremendous interest in applying quantum dots (QDs) is in the field of
clinical diagnostics, where they can be used as luminescent tags for biomolecules.1-3
QDs are ideal fluorescent tags for simultaneous detection of multiple analytes, because
they have symmetric and narrow emission peaks and can be excited by radiation of any
wavelength shorter than that of their emission. They also have large extinction
coefficients, long fluorescence lifetimes, and excellent photo-stability.
In addition to the size and quality of individual QDs, their concentration in a
liquid sample plays a critical role in determining the measured photoluminescence (PL)
intensity per QD, a quantity that affects the ultimate sensitivity of an assay. In contrast to
typical colloidal suspensions that consist of particles with sizes similar to the wavelength
of visible radiation, the size of QDs is one to two orders of magnitude smaller. Light
propagation in concentrated colloidal suspensions has been a subject of research for many
years due to the nonlinear interaction between radiation and particles.4 QD dispersions
have a certain degree of polydispersity and, since the particles absorb as well as emit
light, re-absorption of emitted radiation by larger QDs is also possible.
In this chapter, we investigate the optimal concentration and the corresponding
average inter-QD spacing that maximizes the emitted PL emission intensity of ZnSe and
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CdSe/ZnS core and core/shell QDs.5 The knowledge obtained in this chapter is quite
applicable in the design of QD-based biosensors in order to maximize the amount of light
collected from the QDs.

3.2

Experimental Methods and Procedures

3.2.1

Dilution of ZnSe Core and CdSe/ZnS Core/shell QDs

ZnSe core and CdSe/ZnS core/shell QDs were synthesized of varying sizes
according to procedures discussed in Chapter 2 and detailed in literature; 6-10 d= 2.6 nm,
3.0 nm and 3.6 nm for the former and d=5.9 nm, 6.5 nm and 7.1 nm for the latter. The
QD samples were dispersed in various organic solvents, and the PL spectra of the
dispersions were measured as the samples were diluted. The as-synthesized ZnSe QDs
(capped with HDA and TOP) were dispersed in either methanol or butanol without
additional cleaning steps. The concentrations (or volume fractions) of the ZnSe QDs
were calculated based on mass balance and assuming complete conversion of the ZnSe
precursor into QDs. An example is provided in the Results & Discussion section (3.3.2).
The CdSe/ZnS core/shell QDs (capped with TOP/TOPO/HDA) were first
precipitated with ethanol to remove excess organic ligands (i.e. the coordinating growth
solvent) and then redispersed in hexane for the measurements. The concentrations were
determined as stated in Section 2.3.6 and reference 11. The PL emission data were
acquired using cuvettes with a 1-cm path length (either quartz or polystyrene) and using
either a FluoroMax2 or FluoroLog3 spectrofluorometer (Horiba Jobin Yvon). The slit
width was set for each dilution series and held constant such that the measured PL
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intensity was within the dynamic range of the instruments. The excitation wavelength,
instrument and solvent used will be specified with the data when appropriate. All data
presented are background subtracted.

3.3

Results and Discussion

In this section, we first discuss the kinds of optical interactions to expect from QD
PL emission experiments. Next, we analyze the dilution effects on the PL emission ZnSe
QDs, followed by studying the same for CdSe/ZnS core/shell QDs. Finally, we consider
the effects of the excitation radiation on the measured emission from the nanocrystal
dispersions.

3.3.1

Expected Optical Interactions of QD Photoluminescence experiment

Due to the size-dependent spectroscopic properties of QDs and the size dispersion
of a typical QD sample (~ 10 %)6,12 they may exhibit optical interactions that are
different from classical non-fluorescent colloidal particles (i.e. silica or latex particles) as
well organic fluorophores. The three expected interaction illustrated in Figure 3.1
include: 1) direction excitation, where the excitation light reaches the QDs and the
particles emit light that reaches the detector. 2) scattering, where the optical density of
the sample prevents either the excitation light or the emitted light from reaching the QD
or detector, respectively. 3) indirect excitation, where the emission of the smaller QDs,
which will be higher in energy or shorter in wavelength than the larger QD, gets absorbed
by the larger QDs. The larger QDs, as a result, then emit light which can be detected or
scattered.
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3.3.2

ZnSe QD Optimal Concentration

As-prepared ZnSe QDs were dispersed in butanol to form dispersions of
nanoparticles and their emission spectra were measured as the samples were diluted. The
excitation wavelength used for these experiments was 350 nm. The PL spectra for four
different dilutions of a QD sample with an average size of 3.6 nm show that there is a
blue shift in the collected light as the concentration decreased (Figure 3.2). The figure
also shows that the maximum PL intensity was obtained for an intermediate QD
concentration of 2.0x10-6 M (curve 2). These phenomena can be explained by
considering the absorption of both the incident and emitted radiation as they travel
through the QD dispersion. With dilution, the excitation radiation is able to excite a
higher percentage of the QDs in its path due to reduced scattering and increase direct
excitation. At the same time, indirect excitation is also decreased. This can lead to the
initial increase of the overall recorded light intensity with increased dilution, until the
decrease in the total number of QD emitters due to dilution leads to a reduction in the
overall recorded light intensity. The blue shift in the recorded PL spectra with increased
dilution is attributed to the decreased indirect excitation or re-absorption of the emitted
radiation by the larger-than-average QDs in the dispersion. This enables a higher
proportion of the radiation emitted by the smaller-than-average QDs to reach the detector,
which exhibit bluer emissions.
To correct for changes in particle number density at various dilutions, the
measured peak PL intensity was divided by the number of QDs in the sample volume to
obtain an apparent PL intensity value per excited QD. The peak recorded PL intensity
per QD is plotted as a function of QD concentration for ZnSe nanocrystals of three
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different average sizes in Figure 3.3. In all three dilution series, the PL intensity per QD
increases with decreasing QD concentration, until it reaches a plateau. The plateau value
is the apparent emission intensity of a single QD in the absence of interference from
neighboring particles. The onset of the plateau corresponds to the optimal dilution level
that maximizes the overall recorded PL intensity from the dispersion.
The optimal value of the QD concentration can be used to estimate the minimum
possible inter-particle distance that can suppress destructive interference between the
particles. The number of QDs in each batch was estimated by assuming complete
conversion of the limiting reactant, diethylzinc, to ZnSe. For example, the QDs were
grown in a batch solution that had a total volume of 25 mL. In this volume 0.9 millimoles
of diethylzinc, assuming complete conversion, would be converted to 1.7×1018 QD
particles with an average size of 3 nm. By collecting a certain volume of this mixture and
diluting it with a known volume of solvent, the number of QDs per volume of the final
dispersion can be calculated. The average inter-QD spacing in each dispersion was
estimated by assuming a random distribution of the particles in the volume of the
dispersion.
Figure 3.4 shows the normalized PL intensity per QD as a function of the interQD spacing. The PL intensity values in each dilution series were normalized with the
maximum value from each series shown in Figure 3.3. The data indicates that, for each
QD size, attenuation of the measured peak PL intensity occurs below a minimum interQD-spacing. The optimal QD spacing, Lo, corresponds to the onset of the departure of
normalized PL intensity from unity (<0.95) as shown in Figure 3.4. Lo was estimated to
be approximately 148 nm, 98 nm, and 67 nm for QDs with average sizes of 3.6 nm, 3 nm,

49

and 2.6 nm, respectively. Lo appears to decrease linearly with QD diameter in this
limited size range. From the large average particle spacing, it is also clear that this
phenomena described here is not Förster Resonance Energy Transfer (FRET), which is a
dipole-dipole interaction that occurs at much smaller distances (< 10nm), but rather a
longer range radiative energy transfer.
The above experiments were repeated using methonal as the dispersing solvent
and measured on two different fluorometers, a FluoroLog3 and a FluoroMax2 (Horiba
Jobin Yvon), to ensure that all observations were solvent and instrument-independent.

3.3.3

CdSe/ZnS QD Optimal Concentration

Dilution experiments of CdSe/ZnS core/shell QDs resulted in similar data which
is presented for ZnSe QDs (Section 3.3.2). The peak PL intensity per QD for CdSe/ZnS
core/shell QDs increase with dilution and reach a plateau (Figure 3.5). The plateau onset
concentration was determined by finding the intersection of the tangents of the curve at
high and low concentrations (Figure 3.5). The concentrations at which the onset of the
plateau occurs around the same regime (i.e. in the order of micro molar) for ZnSe as well as
CdSe/ZnS QDs (Table 3.1). This data validate that the phenomena reported here is indeed
material independent, and should also be valid for other semiconductor quantum dots.
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Table 3.1: Size of the QDs studied and their respective onset concentration
QD Type
Core d (nm) Shell (nm) Total d (nm) Onset Conc. (M)
CdSe/ZnS 1

2.8

1.55

5.9

3.5x10-6

CdSe/ZnS 2

3.4

1.55

6.5

1.9 x10-6

CdSe/ZnS 3

4

1.55

7.1

9.7 x10-7

ZnSe 1

2.6

0

2.6

9.7 x10-6

ZnSe 2

3

0

3

5.2x10-6

ZnSe 3

3.6

0

3.6

3.4 x10-6

3.3.4

The Effect of Excitation Wavelength on Measured Emission

The emission intensity of QDs is dependent on the wavelength of the excitation
radiation; PL excitation spectrum of QDs is similar to its absorption spectrum as
discussed in Section 2.3.2 (Figure 2.5). The absorption spectrum of a CdSe/ZnS sample
is shown in Figure 3.6 along with its emission spectra as the sample is diluted from
3.1x10-6 to 1.4x10-7 M (excited at 350 nm wavelength). The results presented in the prior
two sections were obtained by using 350 nm excitation, which is higher in absorbance
than that of the higher wavelengths. To study the effects of absorbance, an excitation of
500 nm was also used to conduct the PL emission experiments of the three CdSe/ZnS QD
samples.
When the excitation wavelength increased to 500 nm, the PL intensity per QD
decreased as expected from the result presented in Section 2.3.2 (Figure 3.7).
Furthermore, the plateau onset concentration also increased (from 9.7x10-7 to 1.5x10-6
M). This is attributed to a reduction in the scattering events of the excitation light since
the optical density of the samples is lower at 500 nm than 350 nm. Another interesting
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result is that the overall peak emission wavelength is higher for the samples that were
excited with a longer wavelength (Figure 3.7). This is attributed to the elimination of the
emission from smaller-than average QDs, especially those that emit lower than 500 nm in
wavelength since the excitation wavelength is below their bandgap.

3.4

Conclusion

In this chapter, we discussed the optimal concentration of QDs dispersions for
achieving the maximum PL emission from the sample. This optimal concentration
decreases with increasing average QD size and is independent of the dispersing solvent or
type of QDs. The optimal concentration, which arises due to the complex optimal
interactions of the QDs in a PL emission measurement, is however dependent on the
excitation radiation wavelength. The PL emission spectra of QD dispersions exhibit a
blue shift with increased dilution, which is attributed to decreased re-absorption of the
emitted radiation by larger than average QDs. Knowing the QD concentrations that
maximize the recorded PL emission is important for the optimal design of sensors
utilizing QDs as fluorescent beacons.
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UV Excitation

QD Dispersion
Scattering

Indirect Excitation
Direct Excitation

Detector

Figure 3.1: Schematic of the three expected optical interactions that occur in a
photoluminescence emission measurement.
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Figure 3.2: PL emission spectra of ZnSe QDs (d= 3.6 nm) at different dilutions. (1)
4.6x10-5 M, (2) 1.6x10-5 M, (3) 2.0x10-6 M and (4) 1.0x10-6 M. The excitation
wavelength was 350 nm.
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Figure 3.3: Peak PL intensity per QD as a function of ZnSe QD concentration for three
dilution series based on samples QD1 (d = 3.6 nm, □), QD2 (d = 3.0 nm, ○) and QD3 (d
= 2.6 nm, ∆). The samples were excited with 350 nm radiation.
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Figure 3.4. Normalized PL intensity per QD as a function of the inter-QD spacing for
three dilution series based on samples QD1 (d = 3.6 nm, □), QD2 (d = 3.0 nm, ○) and
QD3 (d = 2.6 nm, ∆). Optimal inter-QD spacing increases with the average particle size
of the dispersion.
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Figure 3.5: Peak PL intensity per QD as a function of CdSe/ZnS QD concentration for
three dilution series particles of varying average diameters (d = 7.1 nm, □), (d = 6.5 nm,
○) and (d = 5.9 nm, ∆). The QDs were excited using radiation of 350 nm wavelength.
The onset of the optimal concentration as determined by the intersection of the tangents
of the curve at high and low concentrations.
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Figure 3.6: Absorption spectrum (solid line, left axis) and PL emission spectra (symbols,
right axis) of CdSe/ZnS QD dispersions. The samples concentrations are 1.4x10-6 M
(solid line), 3.1x10-6 M (□), 1.4x10-6 M (○),3.1x10-7 M (∆) and 1.4x10-7 M ( ). The
emission spectra are collected by using an excitation wavelength of 350 nm.
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Figure 3.7: Peak PL intensity per QD (open symbol, left axis) and wavelength (crossed
symbols, right axis) as a function of CdSe/ZnSe QD (d=8.0 nm) concentration. The
dilution series was excited with 350 nm (□) and 500 nm (○) wavelength radiation.
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CHAPTER 4

NEUTRAL BIDENTATE POLY(ETHYLENE GLYCOL) LIGANDS
FOR WATER SOLUBLE NANOPARTICLES WITH EXTENDED
pH AND IONIC STABILITY

4.1

Introduction

Since a large fraction of the total atoms of nanoparticles are distributed on or near
their surfaces (large surface-to-volume ratios), their surface ligands play a critical role in
controlling their reactivity, as well as their chemical and colloidal stability. For QDs, it is
also important to properly passivate the nanocrystal surface in order to maintain their
photoluminescence efficiency. Rendering these nanoparticles dispersible and stable in
aqueous buffer solutions, while maintaining their optical properties intact, is critical for
using them to develop biological applications.
Several strategies that yield aqueous dispersions of QDs have been reported in the
past decade.1,2 These methods can be grouped into two categories: 1- Exchange of the
native TOP/TOPO with hydrophilic ligands, usually comprised of anchor group(s) for
binding to the nanocrystal surface at one end and hydrophilic groups at the other end, to
promote solubility in aqueous solutions.3-6 2- Encapsulating the as-synthesized QDs with
amphiphilic molecules such as lipids or block co-polymers.7-9 Most commercially
available hydrophilic QDs employ encapsulation methods (within polymeric shells or
micelles). The surface modification methods are summarized in Figure 4.1. These
nanocrystals have been used in a variety of demonstrations ranging from live (and fixed)
cell staining to animal imaging. However, these nanoparticles tend to be rather large in
size (diameter >15 nm), due to long chain length (or large molecular weight) amphiphilic
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polymers used to make the nanocrystals hydrophilic, which is a drawback in assays and
applications requiring stringent constraints on overall nanoparticle dimensions.10 Surface
ligand cap exchange can provide high quality water-soluble nanocrystals that are
functional and more importantly small in size. Preparing small hydrophilic QDs is
beneficial to a variety of targeting studies, including use in cellular uptake and imaging,1
renal clearance,11 and the ability to realize efficient Förster resonance energy transfer
(FRET).12,13
The Mattoussi group has previously reported the design of hydrophilic ligands
consisting of thioctic acid (TA) chemically coupled to a tunable poly(ethylene glycol)
(PEG) segment via an esterification reaction. With this simple coupling chemistry, a set
of hydroxy-terminated TA-PEG ligands was generated.3 Following ring opening of the
terminal dithiolane to produce a dithiol group, the resulting dihydrolipoic acid-appended
ligands (DHLA-PEG-OH) allowed effective cap exchange of the QDs. Hydrophilic
luminescent nanocrystals that are stable over a relatively broad range of pH values were
thus prepared.
However, while the hydroxy-terminated DHLA-PEG ligands have been effective
in promoting water dispersion of CdSe-ZnS core-shell QDs, it was recently observed that
the necessary reduction step of the 1,2-dithiolane ring (using sodium borohydride,
NaBH4) to transform TA-PEG-OH to DHLA-PEG-OH can decompose the TA-PEG-OH
if excess NaBH4 was used, presumably due to the labile ester bond. In addition, the
hydroxy group, while often assumed to be relatively inert, can react with certain
functional groups commonly used for bioconjugation (e.g., isocyanate).14 For this reason,
it would be advantageous to improve the design and prepare a robust alternative ligand
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that utilizes an amide linkage, rather than an ester, and presents an inert terminal
function.
This work addresses the above limitations and reports the synthesis of a new
bidentate ligand that is also based on the TA and PEG motifs. In this modified design the
ligands feature an amide bond, instead of an ester, to couple TA to poly(ethylene glycol)
methyl ether and form TA-PEG-OCH3, as shown in Figure 4.2. The poly(ethylene
glycol) methyl ether (methoxyPEG or mPEG), which is commercially available, is
terminated with a hydroxy group on one end and a methoxy group on the other. In
addition, since the mPEG precursor presents only one hydroxy group instead of two as in
references 3 and 4, the synthetic scheme was also substantially improved, while the
purification steps were readily simplified. Following synthesis and purification, we
found that reduction of TA-PEG-OCH3 to produce DHLA-PEG-OCH3 (see Figure 4.2)
was unaffected by the concentration of NaBH4 used (from 1 to 4 times molar excess).
Furthermore, the presence of a methoxy terminal group instead of a hydroxy can
potentially mitigate non-specific interactions, an issue of great importance in biological
systems.15,16 We found that QDs capped with these new ligands were stable over a broad
range of pH values (from 3 to 13). Side-by-side comparison of intracellular
microinjection of QDs capped with DHLA-PEG-OCH3 and DHLA-PEG-OH indicates
improvement in the dispersions of QDs capped with the new ligands inside the cell
cytoplasm. The utility of the newly synthesized ligands was further demonstrated by their
ability to surface-modify gold nanoparticles (AuNPs), where water-soluble AuNPs that
are stable even at high salt concentrations and a broader range of pH values (2 - 13) were
prepared.
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4.2

Experimental Methods and Procedures

4.2.1

Methoxy Poly(ethylene glycol) (mPEG) Ligand Synthesis

The synthesis of DHLA-PEG-OCH3 ligands used for cap exchange with the
nanocrystals can be summarized in four main reaction steps: 1- azide transformation of
the hydroxy group at the end of mPEG using methanesulfonyl chloride and sodium azide,
2- transformation of the azide group to an amine by reduction with triphenylphosphine,
3- coupling of the amine on the mPEG to TA, via N,N’-dicyclohexylcarbodiimide (DCC)
coupling to make TA-PEG-OCH3 and 4- ring opening of the 1,2-dithiolane end group
(via sodium borohydride reduction) to make the final DHLA-PEG-OCH3 ligand.17 The
synthetic scheme described below equally applies to the preparation of ligands having
various PEG molecular weights. In the present study, details of the synthesis,
purification and use for nanoparticle functionalization will be limited to ligands having
average molecular weight mPEG of 550 and 750 Da. We will refer to ligands having
PEG750 throughout the manuscript, unless otherwise stated.
Synthesis of N3–PEG750–OCH3 (1). Poly(ethylene glycol) methyl ether (MW ~

750 Da) (60.0 g, ~8.0x10-2 mol) and methanesulfonyl chloride (11.95 g, 0.104 mol) were
first dissolved in 100 mL of THF in a 500-mL round-bottom flask and the solution was
cooled to ~0 °C under N2 using an ice bath. Triethylamine (16.2 mL, 0.12 mol) was
added dropwise to the reaction flask using an addition funnel. The reaction mixture was
then gradually warmed up to room temperature and left stirring overnight. To this
mixture, a solution of NaHCO3 (7.0 g, 8.33x10-2 mol) in 125 mL of H2O was added, then
followed by sodium azide (8.33 g, 0.128 mol) while stirring. The content was then
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heated to distill off the THF and refluxed for 7 hours. After cooling, the reaction mixture
was extracted three times with ethyl acetate. The combined organic layers were dried
over Na2SO4, filtered and the solvent was evaporated to obtain the product (~75 % yield).
The product was a waxy solid at room temperature. TLC of the product was carried out
using a 10:1 (v/v) CH2Cl2:methanol (MeOH) eluent resulted in Rf ~0.53. 1H NMR (400
MHz, in CDCl3): δ 3.62-3.71 (m), 3.53-3.57 (m, 2H), 3.39 (t, 2H, J = 5.2 Hz), 3.38 (s,
3H)
Synthesis of NH2–PEG750–OCH3 (2). N3–PEG750–OCH3 (46.5 g, ~6.0x10-2

mol) and triphenylphosphine (21.9 g, 8.35x10-2 mol) were mixed in a 500-mL roundbottom flask, dissolved in 400 mL THF and left to stir for 30 minutes. Then, H2O (10
mL, 0.54 mol) was added and the solution further stirred for 4 hours under N2 at room
temperature. The THF was evaporated and 400 mL of a 1 M HCl solution was added to
the mixture. The reaction mixture was then extracted with ethyl acetate (3 times), which
allowed removal of a fast moving by-product as shown by TLC. The reaction mixture
was basified by saturating with NaHCO3, then with NaCl, and extracted with CH2Cl2.
The organic layers are combined and dried over Na2SO4, filtered, and evaporated to
obtain the product (~97 % yield), which was a waxy solid at room temperature. TLC of
the product using a 5:1 (v/v) CH2Cl2:MeOH eluent resulted in Rf ~0.47. 1H NMR (400
MHz, in CDCl3): δ 3.62-3.71 (m), 3.53-3.57 (m, 2H), 3.51(t, 2H, J = 5.2 Hz), 3.38 (s,
3H), 2.87 (t, 2H, J = 5.2 Hz)
Synthesis of TA–PEG750–OCH3 (3). NH2–PEG750–OCH3 (32.8 g, ~4.46x10-2

mol), 4-(N,N-dimethylamino)pyridine (1.10 g, 9.0x10-3 mol), N,N’dicyclohexylcarbodiimide (9.26 g, 4.49x10-2 mol) and 150 mL of CH2Cl2 were mixed in
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a 500-mL round-bottom flask. The content was stirred under N2 and cooled to 0 °C using
an ice bath. Thioctic acid (9.20 g, 4.46x10-2 mol), dissolved in 50 mL of CH2Cl2 was
slowly dripped into the reaction using an addition funnel. The reaction mixture was left
stirring for 2 hours at 0 °C, then slowly warmed up to room temperature and left to stir
overnight under N2. The mixture was filtered through celite, rinsed with ethyl acetate,
and the solvent was evaporated from the filtrate. After evaporating the solvent, the
reaction mixture was diluted with 200 mL of H2O and extracted with ether to remove a
fast moving by-product as shown by TLC. Then the aqueous solution was saturated with
NaHCO3 and the crude product was extracted with CH2Cl2. The combined extracted
CH2Cl2 layers were dried over Na2SO4, filtered and the solvent was evaporated. The
crude product was chromatographed on silica gel with 10:1 (v/v) CH2Cl2:MeOH as the
eluent to obtain the product (~70 % yield), which was a yellow waxy solid at room
temperature. TLC of the product using a 10:1(v/v) CH2Cl2: MeOH eluent resulted in Rf
~0.46. 1H NMR (400 MHz, in CDCl3): δ 6.29 (s, 1H), 3.62-3.71 (m), 3.53-3.57 (m, 4H),
3.46 (t, 2H, J = 5.2 Hz), 3.38 (br s, 3H), 3.08-3.22 (m, 2H), 2.42-2.52 (m, 1H), 2.19 (t,
2H, J = 7.2 Hz), 1.86-1.96 (m, 1H), 1.59-1.78 (m, 4H), 1.40-1.55 (m, 2H)
Synthesis of DHLA–PEG750–OCH3 (4). TA–PEG750–OCH3 (0.33 g, 3.46x10-4

mol) was dispersed in 1 mL of MeOH and 2 mL of H2O mixture; the container was
sealed, purged with N2 and cooled to ~0 °C using an ice bath. NaBH4 (2.7x10-2 g,
7.14x10-4 mol) initially dissolved in 2 mL of H2O was slowly injected into the reaction
mixture, and the solution was left stirring for 2 additional hours at 0 °C. The reaction
mixture was then warmed up to room temperature and left to stir overnight. The content
was diluted with 15 mL of brine, and extracted with CH2Cl2. The combined organic
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phase was dried over Na2SO4, filtered and the solvent evaporated to obtain the product (a
yield of ~97 %), as a white waxy solid at room temperature. The reduced ligand (DHLAPEG750-OCH3) co-spotted with TA-PEG750-OCH3 using a 10:1 (v/v) CH2Cl2:MeOH
eluent show the same position in TLC, but DHLA-PEG750-OCH3 exhibit a band with a
longer tail. 1H NMR (400 MHz, in CDCl3): δ 6.29 (br s, 1H), 3.62-3.71 (m), 3.53-3.57
(m, 4H), 3.46 (t, 2H, J = 5.2 Hz), 3.38 (s, 3H), 2.92 (m, 1H), 2.6-2.8 (m, 2H), 2.20 (t, 2H,
J = 7.2 Hz), 1.85-1.95 (m, 1H), 1.40-1.80 (m, 7H), 1.36 (t, 1H, J = 8.0 Hz), 1.31 (d, 1H, J
= 7.6 Hz)

4.2.2

Cap Exchange of Quantum Dots with mPEG Ligands

Cap exchange of the TOP/TOPO-capped QDs with neat DHLA-PEG750-OCH3
was carried out following the procedure reported in references.3,4 In a typical cap
exchange preparation, ~0.5 mL of as-prepared hydrophobic QDs dispersed in a mixture
of hexane/toluene/butanol (~20-40 µM in QD concentration) was first precipitated by
adding ~10 mL of ethanol. The mixture was then centrifuged and the supernatant
decanted. 5 mL of ethanol was added to the precipitate and the mixture was briefly
sonicated to break up the pellet. The dispersion was centrifuged again, and the
supernatant decanted. 0.5 mL (~5x10-4 mol) of the ligand was added to the precipitated
QDs, and the vial was sealed and purged with N2. In general large excess of ligands
(~50,000 ligands per QD) is used to allow effective cap exchange, because the process is
driven by mass action. Ethanol (0.5 mL) was then injected via a syringe into the vial, and
the mixture was stirred for several hours at 60-80 °C. As the sample homogenized, it
became clear, which is indicative of an effective cap exchange. The solution was cooled
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to room temperature and then precipitated with a mixture of hexane, ethanol, and CH2Cl2
(roughly in a mixing ratio of 1.0:1.2:0.1). The sample was then centrifuged; the
supernatant discarded and residual solvents were evaporated over flowing N2. The
relatively dry and newly capped QDs were re-dispersed in deionized water to form a clear
dispersion of nanoparticles. The dispersion was subsequently filtered through a 0.45 µm
hydrophilic membrane (Millipore). Excess free solubilized ligands were removed from
the final dispersion by exchanging the solvent with fresh DI water 2-3 times using a
centrifugal filtration device (Millipore, MW cutoff of 50 kDa). The cap-exchanged QDs
were characterized using absorption, fluorescence, and FT-IR spectroscopy. The QD
concentrations were determined from UV-Vis absorption measurements following the
procedure reported by Leatherdale et al.18

4.2.3

Cap Exchange of Gold Nanoparticles with mPEG Ligands

Cap exchange of gold nanoparticles (AuNPs) with the new ligands was preformed
on commercially available citrate-stabilized colloidal gold solutions (Ted Pella, Inc.,
Reading, CA).19 We also found that both 1,2-dithiolane- and dithiol-terminated ligands
provided effective cap exchange with AuNPs, a clearly different result from what we
have observed for QDs; for the latter ring opening of the 1,2- dithiolane is required. TAPEG-OCH3 or DHLA-PEG-OCH3 was diluted in 1 mL of DI water (35 mg, ~3.7x10-5
mol) and the solution pH was adjusted to ~10 by adding drops of 0.5 M NaOH. The
ligand solution was added to citrate-stabilized AuNPs (4 mL, ~1.4x1012 particles/mL)
and the dispersion stirred overnight (~18 hrs) at room temperature. For cap exchange on
AuNPs we used an excess of 4x106 ligands per nanocrystal, which corresponds to 400
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ligands per surface atom, assuming that a 15-nm AuNP has ~10,000 surface atoms. The
mixture was then filtered through a 0.45 µm hydrophilic membrane, and excess ligand
was removed by washing with water (2-3 times, ~15 mL each cycle) using a centrifugal
filtration device (Millipore, MW cutoff of 50 kDa), as described above. The capexchanged AuNPs were characterized by FT-IR and absorption spectroscopy. The
extinction coefficient of the 15 nm AuNPs (as-received concentration of ~1.4x10-12
particles/mL) was determined to be ~4.2x108 M-1 cm-1 at their plasmon peak of 524 nm.
The measured extinction coefficient is consistent with literature values and was used to
determine the concentration of the AuNPs after cap exchange.20,21

4.2.4

pH stability of Cap-Exchanged Nanoparticles

After cap exchange, the stability of the nanoparticles (QDs and AuNPs) in both
acidic and basic conditions was monitored over time. For comparison, commercially
purchased polymer coated carboxyl QDs (Invitrogen, CA) were also tested. As provided
these QDs are stored in 50 mM borate buffer, which was exchanged with DI water using
a centrifugal filtration device (Millipore, MW cutoff of 50 kDa). Buffers of varying pH
were prepared by adding 2 M HCl or NaOH to 1x phosphate buffer saline (PBS). The
samples were visually monitored for signs of aggregation over time and photographs
were taken at various time intervals under UV or white light illumination for QDs and
AuNPs, respectively.
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4.2.5

Live Cell Injection and Imaging with Cap-exchanged Quantum Dots

COS-1 cell lines (ATCC, Manassas, VA) were cultured following the procedures
previously described.22 Microinjection was performed in sterile Lab-Tek chambered
coverslips (Nunc, Rochester, NY). The chambers were coated with 50 µg/mL fibronectin
(Sigma-Aldrich) in sodium bicarbonate buffer pH 8.5, and ~ 2 × 104 cells were seeded
into the wells and cultured overnight. DHLA-PEG-OCH3 and DHLA-PEG-OH capped
QDs (5 µM concentration, in 0.5x PBS) were directly injected into adherent cells using
an InjectMan® NI2 micromanipulator equipped with a FemtoJet Programmable
Microinjector (Eppendorf, Westbury, NY). This setup allows the injection of femtoliter
aliquots of conjugate solution to individual cells. The cell cultures were subsequently
imaged using an Olympus IX-70 microscope (Center Valley, PA). Cultures were excited
using 488 nm light provided by a Xe lamp source combined with a 488 nm band pass
filter (Chroma Technology, Rockingham, VT). The fluorescence emission was separated
from the excitation signal using a 500 nm long-pass filter (Chroma Technology,
Rockingham, VT) and collected on a DP71 color digital camera (Olympus, Center
Valley, PA). Differential interference contrast (DIC) images of the cell cultures were
also collected on the same Olympus IX-70 microscope using a bright field source. The
images were then analyzed using DP Manager Software (Olympus, Center Valley, PA)
and Image J (NIH, Bethesda, MD). After injections, the cells were incubated at 37°C in
Ringer’s solution and were periodically taken out to ambient conditions for microscopy
imaging.
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4.3

Results and Discussion

4.3.1

Synthesis and Characterization

The synthetic scheme and chemical structures of the ligands made and used for
cap exchange are illustrated in Figure 4.2. The synthetic design essentially follows our
previously published rationale.4 The terminal hydroxy group on the poly(ethylene
glycol) methyl ether (mPEG) was first converted to an azide via a two-step reaction. The
first consisted of converting the hydroxy to a methanesulfonyl intermediate group and
then to an azide by sodium azide (step a). In the second, the azide group was
transformed to an amine using triphenylphosphine (step b), followed by attachment to
thioctic acid (TA) via DCC coupling to provide TA-PEG-OCH3 (step c). Finally, the 1,2dithiolane ring on the TA unit was reduced with NaBH4 (step d). In reaction steps a, b
and d, the solubility of the resulting molecules was taken into careful consideration and
the products were purified by extraction, rather than column chromatography, an
approach that has greatly simplified the overall synthetic scheme.
We should also emphasize that because the mPEG precursor presents only one
reactive end group, the synthesis of the amino-PEG (NH2-PEG-OCH3) was carried out
without requiring a biphasic reaction as done in references.4,23 Using the mPEG not only
simplified this synthetic step, but the yield was also dramatically increased to values
exceeding 90 %; we reported a yield of ~50 % for the NH2-PEG-N3 reaction in reference
4

. In addition, only ~1:1 molar ratio of PEG to TA was used for the present coupling

scheme. This constitutes a major improvement compared to the esterification reaction we
reported in reference 3, where a 10 fold molar excess of PEG was used in order to
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suppress the formation of bis-substituted PEG (TA-PEG-TA). These two advantages
make the synthetic route more efficient than previously reported.
One of the key features of the TA-PEG-OCH3 ligand (3) is the presence of an
amide bond, instead of an ester, which leads to improved ligand stability. For example,
we found that reduction of ligand 3 in the presence of even 3-4 folds excess NaBH4 did
not affect the coupling integrity, whereas even equimolar ratio of NaBH4 to TA-PEG-OH
occasionally induces decomposition of the molecule, most likely a consequence of the
labile nature of the ester bond. The 1H NMR data shown in Figure 4.3 clearly prove that
the spectrum of compound (3) is a composite of the individual spectra collected for the
two precursors (mPEG and TA), with a very pronounced peak at 3.6-3.7 ppm
characteristic of the PEG segment, a singlet peak at 3.38 ppm attributed to the methoxy
group, and a new broad singlet peak at ~6.3 ppm attributed to the amide proton.3,4
Following ring opening, the 1H NMR spectrum of DHLA-PEG-OCH3 (4) shows
additional triplet and doublet peaks at ~1.3-1.4 ppm, which are attributed to the open
dithiol protons (Figure 4.3). In addition to the amide proton peak at ~6.3 ppm, the triplet
peak attributed to the protons from the PEG segment closest to the amide bond (3.46
ppm) and the triplet from the protons next to the carbonyl (2.20 ppm) were also observed
in compound (4). This confirms that the integrity of the coupling via the amide bond was
maintained even when the 1,2-dithiolane reduction was carried out using 3-fold excess of
NaBH4.
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4.3.2

Cap Exchange of Luminescent QDs

Cap-exchange of the native TOP/TOPO ligands with DHLA-PEG750-OCH3 (4)
was effective in promoting the transfer of the nanocrystals to buffer solutions at both
acidic and basic pHs. Following transfer into the buffer solutions, the QDs maintained
their absorption and luminescence characteristics, as shown in Figure 4.4 for a typical
QD sample emitting at 552 nm and cap-exchanged with DHLA-PEG750-OCH3 (4);
spectra of TOP/TOPO-coated QDs (control) dispersed in CH2Cl2 are shown for
comparison. However, a reduction of the PL quantum yield compared to the
TOP/TOPO-capped samples was observed. In general the quantum yield experiences
about 50 % reduction compared to TOP/TOPO-capped nanocrystals dispersed in hexane
or toluene, a result that is consistent with our previous findings using the DHLA-PEGOH cap.3,4 Cap exchange with DHLA-PEG550-OCH3 (PEG MW~550 Da) also
promotes water-solubility of luminescent QDs. These water-soluble QDs are stable,
aggregate free and brightly luminescent, for at least several month in water. This
indicates that the PEG segment dominates the solubility of the QD-ligand in aqueous
environments since both the dihydrolipoic acid and methoxy groups are hydrophobic.

4.3.3

Cap Exchange of Gold Nanoparticles

To extend the utility of our ligand design we performed cap exchange on
commercially available citrate-functionalized AuNPs (Ted Pella, Inc., Reading, CA).
Cap exchange was carried out successfully using both TA-PEG-OCH3 (3) and DHLAPEG-OCH3 (4). Figure 4.5 shows the absorption spectra of solutions of 15 nm AuNPs
before and after cap exchange with either of the ligands. The data clearly indicate that
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substituting the citrate with either of the two ligands did not affect the native properties of
the nanoparticles, with essentially no change in the absorption features and absence of
any aggregate formation following the surface modification. The effective cap exchange
of AuNPs using TA-PEG as well as DHLA-PEG ligands is attributed to the strong
affinity of the dithiol end group (soft base) to the gold surface (soft acid).24-27 The ability
to perform cap exchange of metallic nanoparticles using 1,2-dithiolane without ring
opening is potentially advantageous, because it reduces the number of reaction steps
needed while still benefiting from the stronger bidentate coordination (compared with
single thiol) to the nanoparticle surface. This is drastically different from cap exchange
of QDs, where opening of the dithiolane ring is always required.
To further verify the effectiveness of the cap exchange on AuNPs, we compared
the stability of the citrate-functionalized and DHLA-PEG-OCH3-capped AuNPs in the
presence of excess electrolyte (i.e., NaCl). Although the as-received citratefunctionalized nanoparticles were stable at low counter-ion excess, we found that when
NaCl concentration was increased (to ~100 mM) the AuNPs readily precipitated (see
inset in Figure 4.5). In comparison, we found that after cap exchange with TA-PEGOCH3 or DHLA-PEG-OCH3, dispersions of AuNPs were stable and aggregate-free at ion
concentrations exceeding 1 M NaCl (see inset in Figure 4.5). Additional stability tests
indicate that the newly-capped AuNPs are stable and aggregate-free at least for several
months in 1 M NaCl. This demonstrates the ability of the TA- and DHLA-based PEG
ligands to effectively cap the AuNPs and improve their thermodynamic stability, even in
the presence of high concentrations of an excess counter-ion.
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4.3.4

FT-IR of Cap-exchanged Nanoparticles

FT-IR measurements, shown in Figure 4.6, were performed on QDs and AuNPs
before and after cap exchange to confirm that the surface ligands were indeed attached to
the nanoparticles. The data show that spectra collected for the solution of cap-exchanged
QDs and AuNPs are similar to those of the free ligand (i.e. they exhibit all the same
major bands). Most notably, the spectra of cap-exchanged nanoparticles exhibit sharp
bands at 1670 cm-1 and 1540 cm-1, which are attributed to the amide I (C=O stretch) and
amide II (N-H bending) from the amide bond that links the TA to mPEG, as does the free
ligand spectrum. These two distinct bands are, however, not present in the spectra of
TOP/TOPO-QDs or citrate-stabilized AuNPs. Furthermore, the large band at 1590 cm-1
(C=O stretch from citrate) measured on the citrate-stabilized AuNPs was not present in
the cap exchanged AuNPs. This data suggests that effective cap exchange of both QDs
and AuNPs using the newly synthesized DHLA-PEG-OCH3 ligands has indeed taken
place.

4.3.5

pH Stability of Surface-Modified Nanoparticles

The stability of QDs and AuNPs capped with the mPEG- appended DHLA and
TA ligands was also tested under various pH conditions. For comparison, the pH effects
on commercially available polymer-encapsulated nanocrystals were also studied. Figure
4.7A shows the fluorescence of several solutions of green-emitting QDs cap-exchanged
with DHLA-PEG-OCH3 dispersed in 1x PBS over the pH range 3-13. The images show
that the dispersions are stable for over one week; at pH levels between 4 and 11, these
solutions are stable for at least one month. These findings confirm and expand our
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previous stability results using OH-terminated ligands; DHLA-PEG600-OH-QDs were
stable over a narrower pH range (5-10).3,4 Similar experiments performed on polymerencapsulated QDs (Invitrogen) showed that dispersions of these nanocrystals are stable
only at neutral to basic buffer conditions. Nanocrystals aggregate immediately following
transfer to PBS buffers under acidic conditions, as shown in Figure 4.7B. At pH 13, the
nanocrystals also exhibit a red shift of the photoluminescence shortly after transfer into
the buffer and macroscopic aggregation after 1 week. We should emphasize that the PL
yield of these solutions stays unaffected during these tests. Indeed, when aggregates slowly form
(e.g., at unfavourable pH), the QDs stay luminescent throughout the experiments. The small
aggregates slowly grow with time and sediment at the bottom of the vial.

Dispersions of DHLA-PEG-OCH3-AuNPs in PBS buffers were stable over the pH
range 2-13 for at least three months, as shown in Figure 4.8. The stability of QDs and
AuNPs capped with of the new set of ligands offers a great deal of flexibility for using
these hydrophilic nanoparticles for biological experiments, where harsh conditions are
ubiquitous. For example, many cellular organelles are maintained at acidic conditions
and rich in dissolved ions.

4.3.6

Extended Stability of Surface-Modified QDs in Live Cells

In previous work, Uyeda et al. has shown that appending a PEG-hydroxy segment
onto DHLA could improve the stability of luminescent DHLA-PEG600-OH-QDs in
acidic buffers and QDs microinjected into the cytoplasm of HeLa cells, particularly when
compared to DHLA-QDs.3 The terminal hydroxyl group on DHLA-PEG600-OH we
used in references 3 and 4, is still reactive (e.g. isocyanate14 or via DCC coupling). To
test whether the presence of the methoxy terminal group could provide additional
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advantages to the new ligands compared to DHLA-PEG600-OH in intracellular studies,
we microinjected live COS-1 cells with QDs capped with either DHLA-PEG600-OH or
DHLA-PEG750-OCH3 and followed the fluorescence distribution in the cells up to 32
hours post injection.17 Representative fluorescence images, shown in Figure 4.9, indicate
that cells microinjected with either QDs exhibit strong emission from the QDs after 32
hours of incubation in Ringer’s solution. The slow decrease of the detected signal is
attributed to the ion-rich media used for cell culturing; we have previously observed that
the fluorescence of QDs persists in buffers and DI water over extended periods of time
under continuous illumination.28 Images show that the nanocrystal distribution remains
perinuclear for both sets of surface-functionalized QDs. They also show that punctuate
fluorescence patterns progressively develop in the cells microinjected with DHLAPEG600-OH-QDs over the experimental time frame, a result similar to our earlier
observation using HeLa cells in reference 3. In comparison, the fluorescence pattern for
DHLA-PEG-OCH3-QDs is more homogeneous throughout the 32 hour “incubation”
time. These preliminary results are promising. They clearly indicate that improved
intracellular stability and reduced levels of non-specific interactions characterize QDs
capped with the methoxy-terminated ligands (DHLA-PEG-OCH3-QDs) compared with
those functionalized with ligands that have an ester linkage and present OH terminal
groups (DHLA-PEG-OH-QDs). This also leads us to anticipate that in addition to the
difference between the amide and ester bonds, the terminal groups presented on the
nanoparticles play an important role in promoting or reducing non-specific interactions in
particularly in ion-rich growth media and inside live cells. Additional experiments to
further clarify and understand the effects of the nature of the terminal end groups of PEG-
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based ligands on the long term behavior in growth media and inside live cells are in
progress. Results will be detailed in future work.

4.4

Conclusion

We reported the synthesis and characterization of a new set of ligands made with
poly(ethylene glycol) methyl ether (mPEG) and thioctic acid (TA), and further used them
for surface modification of quantum dots (QDs) and gold nanoparticles (AuNPs). These
ligands feature a more stable amide bond between TA and PEG and a methoxy-terminal
group, which constitute an improvement over our previous design using an ester linkage
and an OH terminal group.3 The new ligands are chemically more stable and present
more inert terminal functions. The synthesis and purification were also simplified and
made more efficient by starting with a precursor that has only one reactive group, namely
poly(ethylene glycol) methyl ether. In three simple and efficient reaction steps TA is
coupled to mPEG, resulting in TA-PEG-OCH3 ligands. These ligands were subsequently
reduced by NaBH4 to yield dithiol-terminated PEG ligands with no loss of the precursor
integrity. We demonstrated the utility of DHLA-PEG-OCH3 ligands by performing cap
exchange on QDs and AuNPs to promote their dispersion in aqueous buffers and over a
broad range of pHs and salt conditions. The new ligands can be combined with other
reactive DHLA–PEG ligands in one cap exchange step to yield QDs with controlled
fraction of reactive groups (e.g., amine and carboxyl) on their surface. Absorption and
fluorescence measurements combined with gel electrophoresis confirmed that cap
exchange with both neat and mixed ligands of QDs was effective and that control over
the molar fractions of surface ligands was achieved. The stability and inert nature of
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DHLA-PEG-OCH3-QDs were further tested in live cells, where perinuclear dispersion of
homogeneous fluorescence pattern in the cell cytosol was observed 32 hours post
injection, indicating that by altering the terminal group to OCH3 non-specific interactions
with the ion-rich cytoplasm could be reduced. We have also shown that the new ligands
(TA- and DHLA-PEG-OCH3) can be used to surface-modify gold nanoparticles and
further enhance their stability in solutions containing a high excess of counter-ions as
well as in a wide range of pH conditions. These results provide an additional tool for
researchers seeking more stable and versatile QDs, AuNPs and other metallic
nanoparticles in biologically relevant conditions (media that are rich in salts, ions and
over a broad pH range).
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Figure 4.1: Methods used to prepare water-soluble QDs. (a,b) QDs cap exchanged with
MAA and DHLA, respectively. (c) QDs cap exchanged with silanes to from a shell of
silica. (d, e) using hydrophobic interactions with native ligands using phospholipids or
amphiphilic polymers. (figure adapted from ref. 2)
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Figure 4.4: Absorption spectra of as-prepared QDs capped with TOP/TOPO in
CH2Cl2 (red, dotted line) and QDs that were cap-exchanged with DHLA-PEG750OCH3 (blue, solid line). The two spectra are normalized to the first exciton peak.
Inset: Normalized fluorescence spectra of as-prepared QDs and QDs cap-exchanged
with DHLA-PEG-OCH3. The QD concentration used in these experiments were ~100
nM.
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Inset: Images of citrate-stabilized AuNPs in H2O and 30 minutes after addition of 0.1
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Figure 4.6: FT-IR spectra of (A) TOP/TOPO-QDs, (B) DHLA-PEG-OCH3-QDs,
(C) TA-PEG-OCH3 ligands (shown twice for easy cross-reference), (D) as-purchased
citrate stabilized AuNPs, (E) TA-PEG-OCH3-AuNPs. The arrows indicated the
bands attributed to amide I and II, which originate from the amide bond that links TA
to mPEG. Additional experimental details are provided in the experimental section.
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Figure 4.7: Images of water-soluble QD dispersions for pH stability study. (A)
Luminescence image of DHLA-PEG-OCH3 cap-exchanged CdSe-ZnS QDs (λem=552
nm) in PBS at varying pH after 8 days and 36 days storage at 4°C. Vial 6, containing
CdSe-ZnS diluted with DI water, serve as a control sample. (B) Luminescence image of
commercially available carboxylated CdSe-ZnS QDs (λem=565 nm) in 1x PBS at varying
pH after 30 minutes and 7 days of storage at 4°C. Vial 6, containing as-received QDs (in
50mM borate) diluted with DI water, serves as a control sample. Samples were excited
with a hand-held UV lamp at 365nm, and had ~0.5 µM concentration.
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Figure 4.8: Image of AuNPs in PBS of varying pH after 3 weeks at room
temperature. Vial 1-4 and 6-8 contain AuNPs capped with TA-PEG-OCH3 in pH 2.0,
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Figure 4.9: Micrographs of COS-1 cells injected with 552 nm emitting QDs capped with
DHLA-PEG750-OCH3 (top) and DHLA-PEG600-OH (bottom) and monitored over 32
hours after microinjection. Following microinjection, cells were stored at 37 °C in
Ringer’s solution.
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CHAPTER 5

ENHANCED STABILITY OF WATER-SOLUBLE GOLD NANOPARTICLES
VIA BIDENTATE POLY(ETHYLENE GLYCOL) LIGANDS

5.1

Introduction

Inorganic nanoparticles such as those made of metallic, semiconducting and
magnetic materials have attracted a tremendous interest for use in biological and medical
applications.1-4 In particular, there has been an extensive work aimed at developing gold
nanoparticles (AuNPs) as scattering and/or plasmonic probes, platforms for drug
delivery, and for localized heat treatment of cancer infected tissue.5-7 These applications
and others require that the nanocrystal be stabilized in buffer media or biological
environments that are rich in salt. Water-soluble AuNPs that are uniform in size, stable
under high ionic concentration, over a broad pH range, and surface-functionalized with
target reactive groups/functions are thus desired for most of these applications.
A common approach for promoting hydrophilicity and bioconjugation of AuNPs
has involved the use of cap exchange or surface modification of citrate-capped
nanocrystals (i.e. reduced from AuCl4-) with often thiol-terminated ligands.8,9 These
include thiol-terminated poly(ethylene glycol)s (PEGs), DNAs and aptamers. This
strategy promotes inter-particle steric hindrance which prevents them from aggregating in
buffer solutions and permits control over their size and interface with the surrounding
solution/environment; citrate-functionalized AuNPs are charge-stabilized and tend to
aggregate in the presence of added salts.9,10 Since citrate reduction and stabilization
provides AuNPs with size regime spanning ~2 to 100 nm, an array of nanoparticles with
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different sizes and capped with a variety of functional ligands can be made using this
simple ligand exchange strategy.11,12 As a result, a tremendous effort has been invested
in developing surface ligands that enhance the stability and biocompatibility of AuNPs.
We should also emphasize that there has been an effort geared towards synthesis
of AuNPs (also known as monolayer protected clusters, MPC) via a two phase reaction
starting with alkanethiol ligands.13 If a hydrophilic segment is appended onto the ligands,
water-soluble nanoparticles can be made using this route.14 While these nanoparticles are
a substantial improvement compared to their water-insoluble predecessors, these methods
are limited in the obtainable nanoparticle size range.
Ligand-to-nanoparticle binding (such as thiol-to-AuNPs) is usually driven by
metal ion coordination. This implies that ligands presenting multiple anchoring groups
for chelation should produce stronger affinity and anchoring to the metallic surface. We
have shown that dithiol terminated ligands provide a substantially enhanced stability to
CdSe/ZnS quantum dots (as compared to single thiol ligands) in water solutions.15-17 One
would expect that colloidal stability of surface-modified AuNPs should also benefit from
using ligands that present multiple chelating groups, as was demonstrated with quantum
dots. The advantages offered by multidentate ligands for binding to AuNPs compared to
their single point coordination counterparts have been an open question, since one thiolterminated ligands and receptors have performed relatively well in functional assays.14,18
There are a few reports demonstrating the advantages of functionalizing AuNPs with
oligonucleotides and alkanes appended with multiple thiols have reported, but none so far
comparing thiolated PEG ligands of varying coordination numbers.19-21
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We investigated the stability of water-soluble AuNPs cap-exchanged with
modular PEG ligands appended with either mono- and dithiol anchoring groups; we
probed their stability to excess salts, against competition by small molecules
(dithiothreitol, DTT), as well as resistance to sodium cyanide (NaCN)-induced
decomposition. One main feature that distinguishes the present study from other stability
investigations of water-soluble AuNPs via multi-thiol terminated ligands is that our
system features a more complete surface modification of the nanoparticle, while the latter
features only sparse addition of thiolated oligonucleotides ligands to the particle
surface.19,20 In addition, our bidentate ligands feature closely spaced sulfur (thiol)
groups, which may provide better coordination to the NP surface compared to thiolated
oligonucleotides, where thiols are appended at the end of “loosely” correlated alkylchains.19

5.2

Experimental Methods and Procedures

In this section, the synthetic method of single thiol methoxy-PEG ligands is
presented. The ligand was used to render nanoparticles water-soluble, and its ability to
protect the inorganic core is probed by dithiothreitol competition as well as cyanide
decomposition.

5.2.1

Monodentate Ligand Synthesis
AcS-(CH2)5-COOH:22 MeOH was added into a round bottom flask and purged

with N2. Sodium (0.423 g, 1.84x10-3 mol) was dissolved into the MeOH. Upon complete
dissolution of the sodium, thiolacetic acid (1.36g, 1.78x10-2 mol) and 6-bromohexanonic
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acid (1.75g, 8.97 x10-3 mol) was added to the reaction. WARNING: sodium is extremely
reactive, and needs to be handled with care! The reaction mixture was refluxed for 5 h.
After cooling the reaction, it was diluted with H2O (100 mL) and acidified to pH=3 using
1 M HCl. The crude product was then extracted with CH2Cl2 (4x, 50 mL). The
combined organic layers were washed with brine (3x, 50 mL) and DI H2O (2x, 50 mL).
Finally the organic layer was dried over Na2SO4 and the solvent evaporated in vacuo to
obtain the product, which appears as yellow oil. TLC of the product using a 10:1 CH2Cl2
: MeOH eluent results in Rf ~0.57. 1H NMR (400 MHz, in CDCl3): δ 2.87(t, 2 H, J=7.4
Hz), 2.36(t, 2 H, J=7.4 Hz), 2.33(s, 3 H), 1.71-1.55(m, 4 H), 1.43 (m, 2 H)

AcS-(CH2)5-PEG750-OCH3:23 NH2–PEG750–OCH3 (6.31 g, 8.42 x10-3 mol), 4-

(N,N-dimethylamino)pyridine (0.22 g, 1.8x10-3 mol), N,N’-dicyclohexylcarbodiimide
(1.58 g, 7.66x10-3 mol) and 70 mL of CH2Cl2 were placed in a 250 mL round-bottom
flask, and stirred under nitrogen at 0°C. AcS-(CH2)5-COOH (0.8 g, 4.21x10-3 mol) was
dissolved in 30mL of CH2Cl2 and added dropwise to the reaction. The reaction mixture
was gradually warmed up to room temperature, and left stirring over night. The mixture
was then filtered through a plug of celite, the solvent evaporated, and diluted with DI
H2O (100 mL). The aqueous solution was transferred into a separatory funnel and
extracted with ether 3-4 times (100 mL). It was then acidified with HCl to pH~3, and
saturated with NaCl. The crude product was extracted with CH2CL2, dried over Na2SO4
and the solvent evaporated. Finally, the product was purified by silica gel column
chromatography using a 20:1 (v/v) CH2Cl2 : MeOH eluent. Yield ~63%. TLC of the
product using a 10:1 (v/v) CH2Cl2 : MeOH eluent results in Rf ~0.55. 1H NMR (400
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MHz, in CDCl3): δ 6.39 (br s, 1 H), 3.58-3.70 (m), 3.53-3.57 (m, 4 H), 3.41-3.48(m, 2 H),
3.38 (s, 3H), 2.86 (t, 2 H, J = 7.6 Hz), 2.32(s, 3 H), 2.18 (t, 2H, J = 7.2 Hz), 1.54-1.7 (m,
4 H), 1.34-1.43 (m, 2 H)
HS-(CH2)5-PEG750-OCH3: AcS-(CH2)5-PEG750-OCH3 (2.45 g, 2.67x10-3 mol)

was dissolved in MeOH (dried over CaH2, 20 mL) in a 100 mL round bottom flask and
purged with N2. NaOMe (25 % wt/wt solution, 2.5 mL, 1.1x10-2 mol) was injected into
the reaction and the mixture was stirred overnight at room temperature. H2O (10 mL)
was added to the reaction mixture and HCl was added until the mixture reached pH ~3.
CH2Cl2 (50 mL) was added to the mixture, and it was washed with brine (3x, 50 mL).
The organic layer was retained, dried over Na2SO4, and the solvent was evaporated to
obtain the product (yield ~96 %). TLC of the product using a 10:1 (v/v) CH2Cl2 : MeOH
eluent results in Rf ~0.49. 1H NMR (400 MHz, in CDCl3): δ 6.42 (br s, 1 H), 3.71-3.57
(m), 3.57-3.51 (m, 4 H), 3.49-3.41(m, 2 H), 3.38 (s, 3 H), 2.5 (dt, 2 H), 2.19(t, 2 H, J=7.6
Hz), 1.70-1.55(m, 4 H), 1.42(m, 2 H), 1.35(t, 1 H, J=7.8 Hz)

5.2.2

Gold Nanoparticle Cap Exchange

Cap exchange was preformed on commercially purchased citrate-stabilized
colloidal gold solutions (Ted Pella, Inc., Reading, CA) using the mono and bidentate
ligands according to a procedure detailed in reference 10. The amount of ligands used
varied depending on the amount of AuNPs and the size of the nanoparticles used; for
mono- and dithiol ligands, the amount of ligands used was 800x and 400x the
concentration of surface atoms, respectively. This was done to account for the difference
in the number of ligands that can be accommodated per nanoparticle, since the
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monodentate ligands have a smaller anchoring head group (compared to the dithiol, i.e.
on the TA-PEG-OCH3). For example, when cap exchanging 10-nm AuNPs, the ligands
(TA-PEG750-OCH3, 64 mg, ~6.68x10-5 mol or HS-PEG750-OCH3, 116 mg, 1.33x10-4
mol) were diluted in 1 mL of deionized water and the pH of the solution was adjusted to
~10 by adding drops of 0.5 M NaOH solution. While the ligand solution was being
stirred, 4 mL of citrate-stabilized AuNPs (10 nm in diameter, ~5.7x1012 particles/mL)
was added in one smooth and continuous motion and the dispersion was stirred overnight
(~18 hrs) at room temperature. The AuNP and ligand mixture was then filtered through a
0.45 µm hydrophilic membrane, and excess ligand was removed by washing with water
through a centrifuging filter (cut-off molecular weight of 50 kDa, 3x, 15 mL per cycle).
The calculation of the number of surface and total atoms per AuNP is shown in Section 5.2.5.

5.2.3

Dithiothreitol Challenge of Surface-bound Ligands

DTT (175 µL of 2 M, 350 µmol) was mixed with NaCl (70 µL of 2 M, 140 µmol)
in a 0.5 cm x 0.5 cm quartz cuvette and diluted with H2O; the amount of water added
depends on the concentration of the AuNP stock solution. The volumes of water and
AuNP solution added were calculated such that the optical density (OD) of the final
AuNP suspension was ~0.3 (0.6 if in 1-cm path length cuvette), the total volume was 350
µL, the final concentration of DTT was 1 M and NaCl is 400 mM. After adding the

appropriate amount of H2O, the AuNPs were then added swiftly to the NaCl/DTT
solution and mixed thoroughly within 30 seconds and the first absorption spectrum was
measured. The samples were measured every minute at the beginning of the experiments
and the time intervals were increased when appropriate as rate of change of the spectra
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decreased. The final concentration of AuNPs was 62 nM and 1.7 nM for particles of 5
nm and 15 nm, respectively.

5.2.4

Cyanide Decomposition of Water-soluble AuNPs

NaCN (0.5 M solution) was added to a 0.5 cm x 0.5 cm quartz cuvettes; the
volume of NaCN varied from 5-50 µL for AuNPs of 5 nm to 15 nm in size. WARNING:
NaCN is extremely toxic, and needs to be handled with care! The solution was diluted
with water such that the final volume (including AuNPs) was 350 µL. Then AuNP was
swiftly added to the cuvette (100-200 µL, so that OD was ~0.3), mixed thoroughly and its
absorption spectrum measured within 30 seconds. The sample’s absorption spectrum
measured every minute at the beginning of the experiment and the measurement interval
was increased when appropriate. The concentration of CN used in decomposition
experiments of 5-nm, 10-nm and 15-nm AuNPs was 7 mM, 61 mM and 68 mM,
respectively.

5.2.5

Estimate of the number of surface atoms per AuNP

The number of surface atoms per nanoparticle, SA, depends on how many layers
of gold atoms the particle is composed of. It can be estimated by Equation (5.1):
SA=10n2+2

(5.1)

where n is the layer number.8 The smallest cluster, n=1, has 13 atoms, 12 of which are
surface atoms. Each additional layer adds ~0.47 nm (diameter of Au atom) to the
diameter of the nanoparticle. For AuNPs of 5 nm, 10 nm and 15 nm in diameter the
calculated SA per nanoparticle is ca. 1000, 4400, and 9600, respectively. The total
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number of gold atoms per nanoparticle, NAu, can also be calculated using the Equation
(5.2) and the number of cyanide ions per gold atom can be calculated using Equation
(5.3):

4π(d / 2)3
=
VAu

(5.2)

CN
[NaCN]
=
Au [AuNP] × N Au

(5.3)

N Au

where d =15 nm and VAu=5.1x10-2 nm3

5.3

Results and Discussion

5.3.1

Ligand Synthesis

To study the effects of the number of binding groups on the stability of the
surface-modified nanoparticles, two PEG ligands were synthesized; one that contains one
thiol while the other possesses two thiols for binding onto the nanoparticle surface. The
remaining parts of the ligands (i.e. a short alkyl chain, a PEG segment and a methoxy
terminal group) are identical between the two. The bidentate ligand used for this study,
which composes of thioctic acid (TA) appended to a methoxy-terminated PEG (mPEG,
MW~750 Da), was synthesized via a 3 steps procedure (Chapter 4).10 First, the hydroxy
terminal group of the mPEG was converted to an azide by transforming it to a
methanesulfonyl group then to an azide using methanesulfonyl chloride and sodium
azide. Next, the azide group on this precursor was reduced to an amine by
triphenylphosphine, yielding amino-PEG-methoxy (H2N-PEG-OCH3). Finally, thioctic
acid (TA) was attached to the amine group by N,N’-dicyclohexylcarbodiimide (DCC)
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coupling to form TA-PEG-OCH3.24 The monodentate ligand was synthesized using the
same H2N-PEG-OCH3 precursor as the bidentate ligand (Figure 5.1). First, acetyl-thiolhexanoic acid was synthesized by reacting thiolacetic acid with 6-bromohexanonic acid.
Then the acetyl-thiol-hexanoic acid was coupled to H2N-PEG-OCH3 by DCC coupling to
form acetyl-protected thiol-PEG-methoxy (AcS-PEG-OCH3) and finally the acetyl group
was cleaved using sodium methoxide to obtain HS-PEG-OCH3 (Figure 5.1).

5.3.2

Gold Nanoparticle Cap Exchange

Citrate-stabilized AuNPs with different size (5 nm, 10 nm and 15 nm) used in this
study were purchased as colloidal gold solutions from Ted Pella, Inc. (Reading, CA).
When performing cap exchange with HS-PEG-OCH3 and TA-PEG-OCH3 ligands, the
amount of excess ligands used varied depending on the AuNP concentration of the stock
citrate-stabilized solutions and the size of the nanoparticles used; NP size defines the
density of surface atoms available for coordination with the capping ligands. In
particular, we used ligand molar concentration of ~800 and ~400 times that of the
concentration of surface atoms on the NP, for mono- and dithiol ligands, respectively.
The molar concentration used for HS-PEG-OCH3 was twice that of TA-PEG-OCH3, in
order to account for the difference in the coordination number of the ligands. However,
due to the large excess of ligands used during a cap exchange reaction, we believe the
particle surfaces are saturated with the respective molecules; even if every surface atom
binds a ligand, more than 99% of the ligands added will be in excess. On the contrary,
the stability studies conducted on the oligonucleotide-modified AuNPs only contained a
maximum of 100 - 200 ligands per 13-nm AuNPs;18-20 since 13 nm AuNPs contain ca.
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7,300 surface atoms,8 at least 70 % of the surface atoms are unoccupied by the modifying
surface ligand (for comparison, these studies used ~ only 0.03x ligands per Au surface
atom while we used over 400x ligands per surface atom).
The absorption spectra shown in Figure 5.2 for 15-nm and 5-nm AuNPs capped
with both sets of ligands, indicate that the spectroscopic properties of the nanoparticles
are preserved, with similar surface plasmon band (SPB) peaks for the three solutions and
no sign of aggregation. A slight shift of the plasmon peak (~2 nm) is observed for the
newly capped NPs, compared to the as-purchased citrate stabilized nanocrystals. The
ability of both ligands to effectively displace the native citrate on the AuNP surface
results from the strong affinity of the terminal thiol groups (soft base) to the gold surface
(soft acid).8,25,26

5.3.3

Ionic Stability of Water-soluble AuNPs

The first test probed effects of excess salt on the colloidal stability of the AuNPs
in solution. Excess ions can influence the solubility of nanoparticles in two ways. If the
steric stability of nanoparticles in solution is controlled by electrostatic repulsions, as is
the case with citrate-stabilized AuNPs, added excess salt will reduce the Debye screening
length, hence causing van der Waals attractions to become dominant and NP aggregation.
Added excess counterion can also alter the solubility of the surface bound ligands to the
surrounding solvent, thus promoting aggregation build up. Figure 5.3 shows that the aspurchased citrate-stabilized AuNPs are not stable in the presence of 1 M NaCl. These
dispersions rapidly aggregated in the presence of NaCl at concentration as low as 100
mM. In comparison, both HS-PEG-OCH3-AuNPs and TA-PEG-OCH3-AuNPs exhibited
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substantially better stability in the presence of added NaCl, which indicates that effective
cap exchange has taken place; AuNP solubility is now controlled by the hydrophilic
nature of the PEG segment. Effectiveness of the cap-exchange was further confirmed by
FT-IR, where bands attributed to the amide C=O stretch (at 1670 cm-1) and amide N-H
bending (at and 1540 cm-1), measured for the free ligands, are maintained in the spectrum
of the NPs capped with either of the thiolated-PEG ligands (see Chapter 4).10
Dispersions of TA-PEG-OCH3-AuNPs of all three sizes were stable in the presence of
added 1 M NaCl (with no visual signs of aggregation) for at least 2 months (Figure 5.3A
for 15-nm NPs and Figure 5.3B for 5-nm NPs). However, though initially stable in 1 M
NaCl solutions, HS-PEG-OCH3-AuNPs aggregation builds after 18 hours of storage at
room temperature; macroscopic aggregation of the HS-PEG-OCH3-AuNPs is observed
after two days of storage.

5.3.4

Dithiothreitol Challenge of Surface-bound Ligands

To further test the stability of cap-exchanged AuNPs, their spectroscopic
properties were measured in the presence of dithiothreitol (DTT), which is a common
reducing agent used to break disulfide bonds of proteins or other thiolated
biomolecules.27,28 In high concentration, DTT can effectively displace the thiolated
ligands away from the NP surface, resulting in progressive NP aggregation of the
dispersion. At a given DTT concentration, this competition ultimately depends on the
affinity of the initial ligand to the Au surface. NP aggregation is driven by the fact that
DTT alone cannot promote steric stabilization in the presence of the NaCl since the
molecule is too small. DTT competition and displacement of the ligands alters the
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spectroscopic properties of the sample and manifests in a decrease of the SPB peak, along
with an increase in the absorbance at longer wavelengths (Figure 5.4A). The resistance
of the capping ligand to competing molecules was tested by collecting the absorption
spectra of the cap-exchanged AuNPs in the presence of added DTT and NaCl, and
following the rates at which the SPB value decreases and/or the absorption spectrum redshifts with time. We quantified this competition process by defining an aggregation
factor (AF) as the ratio between the optical densities at 615 nm and at the SPB (~524 nm,
the exact wavelength varies several nm depending on the sample), because changes in
solution absorbance due to aggregation are most noticeable at these two wavelengths in
our experiments. Using the AF also reduces effects of small fluctuations in the
absorption spectra with time due to variations in the excitation intensity and changes in
sample concentration due to sedimentation or evaporation with time. If the water-soluble
AuNPs are unstable in the presence of added DTT and NaCl, the aggregation factor will
increase with time. Conversely, if the ligand’s affinity to the Au surface is strong, DTT
competition is slow or ineffective and the nanoparticles stay well dispersed even in the
presence of salt. In this instance, the absorption spectra along with AF will remain either
unaltered, or exhibit weak and slow change with time. Figure 5.4A-B shows the time
progress of the absorption spectra of 15-nm HS-PEG-OCH3-AuNPs and TA-PEG-OCH3AuNPs in the presence of 1 M DTT and 400 mM NaCl. Figures 5.4C shows the
corresponding progression of AF with time. Data clearly show that AuNPs capped with
bidentate TA-PEG-OCH3 exhibited a much stronger resistance to aggregation (thus better
dispersion stability) than those capped with HS-PEG-OCH3. Solutions of HS-PEGOCH3-AuNPs progressively changed color from red to violet to black with time, as
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macroscopic aggregation built up in the samples. The enhanced stability of the dithiol
compared to the monothiol ligand is also shown for 5-nm AuNPs. The absorption
spectrum of 5-nm TA-PEG-OCH3-AuNPs (in the presence of 1 M DTT and 400 mM
NaCl) were more stable over time, whereas HS-PEG-OCH3-AuNPs under the same
conditions aggregated within 90 minutes (Figure 5.4D). Note also that the aggregation
of the 5-nm AuNPs is slower than the 15-nm AuNPs; this may be due to a smaller van
der Waals force in the smaller NPs. Nonetheless, these side by side comparisons of
mono- versus dithiol cap-exchanged nanoparticles suggest that the dominating factor in
providing stable AuNPs against small molecule competition is the number of
coordinating groups per ligand, which is correlated to the binding strength of the capping
ligand. Similar observations were reported for thioctic acid appended oligonucleotides
ligands by Dougan et al.20

5.3.5

Cyanide Decomposition of Water-soluble AuNPs

In the third test, we focused on the ligand’s ability to insulate the nanoparticle and
protect it against cyanide digestion. While the binding strength of the surface ligands is
significant as shown in the DTT competition results above, cyanide digestion
experiments will probe the ligands’ ability to protect the inorganic core against CN
anions in the solution.8,9,29 When CN anions come in contact with the inorganic core,
they complex to the gold ions and progressively etch the nanoparticle surface. This
converts the reddish AuNPs sample into a colorless solution of Au(CN)2- ions.29-31
Figure 5.5 shows the progression of the absorption spectrum of with time following
addition of 7 mM NaCN. There is a clear and time-dependent decrease in the absorption
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spectrum with time for λ > 250 nm. Figure 5.5 (inset) also shows that additional new
features appear in the spectrum for λ < 250 nm, with well defined peaks at 204, 211, 230
and 240 nm (signatures of Au(CN)2- formation) that become increasingly visible with
time.32,33 The progressive decrease in the SPB as AuNPs are etched can be accounted for
by Mie theory; since the surface of the particle is being etched away, the surface plasmon
is also diminished.34 We quantified the rate of decomposition by measuring the timedependent decrease of the SPB absorbance and fitting it to a first order exponential decay
function:

y=y 0 e-t/t D

(5.1)

where tD is the first order decay time and y0 is the absorbance value at t = 0 min.35,36
Comparison between mono versus dithiol capping indicate that digestion of AuNP
by added NaCN depends on the nanoparticle size (Figure 5.6). For these experiments,
the initial absorbance of the samples at the SPB was maintained at ~0.3 (in a 0.5-cm
optical path cuvette), but the concentration of NaCN used was raised with increasing
AuNP size. We used a higher cyanide concentration for solutions of larger NPs to
compensate for the larger number of interior Au atoms in these samples; at similar
nanoparticle concentration, smaller nanocrystals present more surface atoms, which will
require lower concentration of NaCN to digest. Our data indicate that as the NP size
increased from 5 to 15-nm, the relative ability of the ligands to protect the inorganic core
from decomposition changed (Figure 5.6). While TA-PEG-OCH3-AuNPs exhibited
much slower digestion than their single-thiol analog for 5-nm AuNPs (tD was ~ 4 times
larger for TA-PEG-OCH3 ligands, Figure 5.6A), the trend is reversed for the larger, 15nm NPs (tD was ~ 2.5 times larger for HS-PEG-OCH3 ligands, Figure 5.6C). Moreover,
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similar decomposition curves were measured for the intermediate 10-nm AuNPs capped
with either ligand (Figure 5.6B); tD is essentially the same for both set of caps.
This result is very informative, as it highlights the effects of capping layer density
on the NP surface in addition to the effects of the coordination number of the anchoring
group as illustrated in Figure 5.7. The ligand density will depend on two parameters: 1)
with increasing surface curvature of the nanocrystals, the packing density of the ligand
will decrease and 2) the ligands’ molecular architecture will also affect how tightly they
can reside next to each other (Figure 5.7). In the regime where the higher surface
curvature of smaller NPs result in a “loosely” packed organic layer, the affinity of the
anchoring group of the ligand to the surface becomes the dominating factor for its
resistance against cyanide digestion. Thus TA-PEG-OCH3-AuNPs exhibit a slower
digestion rate than HS-PEG-OCH3-AuNPs as shown in Figure 5.6C for 5-nm AuNPs.
Conversely, larger size NPs present a flatter surface, which will result in a more densely
packed organic layer for both ligands, but HS-PEG-OCH3-AuNPs have a larger overall
density of ligands due to the smaller anchoring group as well as a tighter or more linear
molecular structure. Cyanide digestion is weaker for monothiol capped nanoparticles in
this case, as shown in Figure 5.6C for 15-nm AuNPs. This is likely due to an increased
packing density of the PEG segments as well as higher interaction between the 6-carbon
alkyl chains that acts as a hydrophobic barrier to protect the inorganic core from its
environment (Figure 5.7). The 10-nm NPs present an intermediate balance where effects
of coordination number and ligand packing density (i.e. foot print angle), which produced
similar digestion rates for both set of samples. Effects of packing versus geometrical
extension of surface ligands has been a topic of interest for researchers; it has driven the
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development of dendritic ligands, as well as, the investigation of the effect of branching
chemical structures.12,29,33 This study highlights the balance between binding strength of
a surface ligand as well as the packing density which depends on the structure of the
ligand and the geometry of the nanoparticle for which it will be used.

5.4

Conclusion

We have explored the effects of varying the coordination number of molecular
scale ligands on the affinity of such ligands to the surface of Au nanoparticles. We
carried several stability experiments on NPs cap-exchanged (starting with commercially
available citrate-stabilized nanoparticles) with either thiol-terminated PEG-OCH3 or
dithiolane-terminated PEG-OCH3 ligands. We found that ligands presenting higher
coordination number (dithiolane) exhibit much better stability to excess added salt and
against competition from small molecule DTT, compared to their monodentate
counterparts. For the DTT experiments, data showed that there are added benefits of
multidentate ligands to NP stability for the smaller size nanocrystals, where a larger
surface curvature could permit easier access of small molecules in the surrounding
solution to the NP surface. Nonetheless, resistance to NaCN digestion indicated a more
“nuanced” behavior. We found that in addition to coordination number, packing density
of the ligands also plays an important role in the dispersion stability and resistance to
cyanide digestion. There is a clear balance between these two parameters, which
manifest in a size and coordination number dependent digestion curves. For smaller size
NPs, a higher coordination is clearly beneficial, whereas a higher ligand density
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permitted by a lower curvature (characteristic of larger size NPs) would make
monodentate-capped nanocrystals more resistant to cyanide digestion.
The benefits of using higher coordination number ligands for capping these
metallic NPs are substantial in biology, as media that are often rich in excess ions are
often used in biological assays. Furthermore, resistance to DTT offered by TA-PEG
ligands is important, as it indicates that there is added benefit of strong ligand-NP
interactions against competition from a whole array of thiol containing molecules which
are common in biological environments (i.e. glutathione, cysteine).
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Figure 5.3: Images showing better ionic stability of AuNPs capped with TA-PEG-OCH3
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CHAPTER 6

MULTIFUNCTIONAL BIDENTATE POLY(ETHYLENE GLYCOL) LIGANDS
FOR WATER-SOLUBLE AND FUNCTIONALIZED NANOPARTICLES

6.1

Introduction

Quantum dots (QDs) and gold nanoparticle (AuNPs) have generated an increasing
interest for use in developing biological applications as discussed in Chapter 1. Their
successful integration in biotechnology necessitates the preparation of water-soluble
nanoparticles that (i) maintain their spectroscopic properties, (ii) are stable over a broad
range of biological conditions and (iii) are compatible with simple conjugation
techniques.1,2
Chapter 4 reports the synthesis of dihydrolipoic acid (DHLA) appended methoxy
poly(ethylene glycol) (DHLA–PEG–OCH3) as surface ligands (via cap exchange) to
promote the aqueous dispersion of luminescent QDs and AuNPs.3 While those ligands
promote the solubility of the inorganic nanoparticles into aqueous environments, they do
not provide additional chemical functionality for facile attachment to biomolecules such
as proteins, peptides or oligonucleotides.4
In 2007, Susumu et al. reported the synthesis of a series of bifunctional PEG400
(PEG MW~400 Da; repeat units, n=8) ligands, comprised of a dithiol anchoring group
and an additional terminal functional groups (FN; i.e. amine, carboxyl and biotin) for
bioconjugation to biomolecules via commonly used techniques.4,5 In this design, the
central poly(ethylene glycol) segment promotes hydrophilicity, the dithiolane terminal
group anchors onto the nanoparticle surface, and the lateral functional/reactive group
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promotes biological linkage with target biomolecules at the other end (DHLA–PEG–FN,
see scheme in Figure 6.1). Using a combination of DHLA-PEG600-OH and DHLAPEG400-COOH, the authors demonstrated bioconjugation of amine functionalized
rhodamine dyes to cap-exchanged QDs. In that work,5 all the bifunctional ligands were
prepared using PEG400 chains, due to a combination of ease of implementation and
purification. While that series of ligands when combined with DHLA-PEG600-OH
provided biocompatible† water-soluble QDs, the PEG400 bifunctional ligands when used
alone can not provide water-soluble QDs that are stable over time (i.e. they aggregate in
several weeks). This is due to the short hydrophilic PEG chain, which was also reported
by Uyeda et al. for the case of DHLA-PEG-OH.6
This chapter expands on the above progress and describes the synthesis and
characterization of a series of modular ligands having functional end groups using
PEG600 (MW~600 Da, n=12). Extension of the synthetic scheme to ligands with a
PEG600 segment required retooling of the synthetic steps and also led to improvements
of the purification techniques. Cap exchange reactions were carried out with these new
ligands in combination with ligands containing an “inert” terminal group (i.e. DHLAPEG-OCH3 or -OH) to demonstrate tunability of the valency of the surface-modified
QDs. The DHLA-PEG600-FN ligands enable the preparation of water-soluble and stable
QDs that have 0 to 100 % surface bound reactive groups. Conjugation of these
functionalized QDs to organic dyes using common techniques was demonstrated.
Furthermore, we quantified the number of surface bound ligands as well as estimated the
number of accessible functional groups on these cap-exchanged QDs.

†

The term “biocompatible” is frequently used in the field of quantum dots to refer to particles that are
easily conjugated to biomolecules and does not imply non-toxicity as the word is understood in medicine.
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6.2

Experimental Methods and Procedures

In this section, experimental procedures will be presented for ligand synthesis,
QD surface cap exchange, gel electrophoresis of the QDs and bioconjugation of QDs to
organic fluorophores.

6.2.1

Ligand Synthesis and Characterization
Synthesis of N3–PEG600–N3. Poly(ethylene glycol) (MW ~600 Da) (53.2 g,

~8.87x10-2 mol), THF (100 mL) and methanesulfonyl chloride (23.3 g, 0.20 mol) were
placed in a 500-mL round-bottom flask, purged with N2 and cooled to ~0 °C using an ice
bath. Triethylamine (30.3 mL, 0.22 mol) was added dropwise to the reaction while the
mixture was stirred. The reaction mixture was gradually warmed to room temperature
and stirred overnight. The mixture was then diluted with H2O (100 mL) and NaHCO3
(6.3 g, 7.5x10-2 mol) was added to basify the solution. Sodium azide (15.7 g, 0.24 mol)
was added and the biphasic reaction mixture was heated to distill off the THF, and
refluxed for 7 h. After cooling, the reaction mixture was extracted with ethyl acetate.
The combined organic layers were dried over Na2SO4, filtered, and the solvent
evaporated to obtain the crude product. Finally, the product was purified by silica gel
column chromatography using 15:1(v/v) CH2Cl2:MeOH as the eluent (~76 % yield),
which was a viscous oil at room temperature. TLC (20:1 (v/v) CH2Cl2:MeOH) Rf = 0.47.
1

H NMR (400 MHz, in CDCl3): δ 3.62-3.71 (m), 3.39 (t, 4H, J = 5.2 Hz). IR (neat):

2868, 2103, 1453, 1115 cm–1.
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Synthesis of NH2–PEG600–N3. N3–PEG600–N3 (10.0 g, ~1.5x10-2 mol) was

diluted in 1 M HCl (25 mL) in a 500-mL round bottom flask, cooled to 0 °C and stirred
under N2. Triphenylphosphine (4.5 g, 1.7x10-2 mol) dissolved in ethyl acetate (125 mL)
was added dropwise into the reaction. The reaction was then warmed up to room
temperature, and stirred overnight. The biphasic mixture was separated to retain the
aqueous layer and discard the ethyl acetate. The aqueous layer, which contains the
product, was washed with ethyl acetate to remove a fast moving by-product (as shown by
TLC). Then, the aqueous layer was basified with KOH (10 g, 0.11 mol) and extracted
with ethyl acetate. The later ethyl acetate layers were dried over Na2SO4 and the solvent
evaporated to obtain the product (~74 % yield) , which was a viscous oil at room
temperature. TLC (5:1 (v/v) CH2Cl2:MeOH) Rf = 0.34. 1H NMR (400 MHz, in CDCl3): δ
3.59-3.70 (m), 3.51 (t, 2H, J = 5.2 Hz), 3.39(t, 2H, J = 5.2 Hz), 2.87 (t, 2H, J = 5.2 Hz).
IR (neat): 3379, 2868, 2107, 1598, 1455, 1119 cm–1
Synthesis of TA–PEG600–N3. NH2–PEG600–N3 (6.73 g, 1.08x10-2 mol), 4-

(N,N-dimethylamino) pyridine (0.41 g, 2.39x10-3 mol), N,N’-dicyclohexylcarbodiimide
(1.65 g, 1.14x10-2 mol) and 100 mL CH2Cl2 were placed in a 250-mL round-bottom
flask, and stirred under N2 at 0 °C using an ice bath. Thioctic acid (2.34 g, 1.13x10-2
mol) was mixed with 30 mL of CH2Cl2 and added into the reaction dropwise. The
reaction was stirred for 2 h at 0 °C, warmed up to room temperature, and stirred
overnight. The mixture was filtered through celite, rinsed with ethyl acetate, and the
solvent was evaporated from the filtrate. After evaporating the solvent, the crude product
was chromatographed on silica gel with CH2Cl2 as the eluent to remove a fast moving byproduct. Following the removable of the fast moving band, the eluent was changed to
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20:1(v/v) CH2Cl2:MeOH to obtain the product (~93 % yield) , which is a yellow viscous
oil at room temperature. TLC (10:1 (v/v) CH2Cl2:MeOH) Rf = 0.50. 1H NMR (400 MHz,
in CDCl3): δ 6.22 (s, 1H), 3.62-3.71 (m), 3.55 (m, 4H), 3.46 (t, 4H, J = 5.2 Hz), 3.40 (t,
4H, J = 5.0 Hz), 3.08-3.22 (m, 2H), 2.42-2.52 (m, 1H), 2.20 (t, 2H, J = 7.2 Hz), 1.86-1.96
(m, 1H), 1.59-1.78 (m, 4H), 1.40-1.55 (m, 2H). IR (neat): 3328, 3075, 2918, 2867, 2105,
1670, 1540, 1456, 1119 cm–1.
Synthesis of TA–PEG600–NH2. TA–PEG600–N3 (5.0 g, 6.16x10-3 mol) was

dissolved in THF (60 mL) in a 250-mL round bottom flask and stirred under N2.
Triphenylphosphine (3.15 g, 1.2x10-2 mol) was added at room temperature under N2.
After 30 minutes of stirring, H2O (3 mL, 0.16 mol) was added and the reaction was
stirred overnight. The solvent was evaporated using a rotorvap, and the contents
transferred into a separatory funnel. A mixture of 1 M HCl (70 mL) and ethyl acetate (50
mL) was added into the separatory funnel. The organic layer was separated and the
aqueous layer was washed with ethyl acetate several more times. Na2CO3 was added
until the aqueous layer was basified, then the product was extracted with CH2Cl2 and
dried over Na2SO4. The product obtained by extraction was sufficiently pure as
determined by NMR, but further purification can be done by column chromatography
using 5:1 (v/v) CH2Cl2:MeOH (~85 % yield). The product obtained in this reaction was
also yellow viscous oil at room temperature. TLC (5:1 (v/v) CHCl3:MeOH) Rf = 0.21.
1

H NMR (400 MHz, in CDCl3): δ 6.22 (br s, 1H), 3.58-3.70 (m), 3.56 (t, 2H, J = 4.8 Hz),

3.45 (m, 2H), 3.08-3.22 (m, 2H), 2.94 (t, 2H, J = 5.2 Hz), 2.42-2.52 (m, 1H), 2.19 (t, 2H,
J = 7.2 Hz), 1.86-1.96 (m, 1H), 1.59-1.78 (m, 4H), 1.40-1.55 (m, 2H). IR (neat): 3298,
3053, 2866, 1666, 1545, 1456, 1109 cm–1.
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Synthesis of TA–PEG600–COOH. TA–PEG600–NH2 (1.06 g, ~1.36x10-3 mol),

succinic anhydride (0.273 g, 2.73 x10-3 mol), CH2Cl2 (10 mL) and triethylamine (0.38
mL, 2.7 x10-3 mol) were stirred overnight at room temperature under N2. The reaction
mixture was then diluted with 1 M HCl solution (60 mL) and the product was extracted
with CH2Cl2. The organic layers were combined, filtered, and the solvent was evaporated
to obtain the product (~85 % yield), which was a yellow viscous oil at room temperature.
TLC (5:1 (v/v) CHCl3:MeOH) Rf = 0.24. 1H NMR (400 MHz, in CDCl3): δ 6.75-6.95 (br
s, 1H), 6.1-6.3 (br s, 1H), 3.58-3.70 (m), 3.56 (t, 4H, J = 4.8 Hz), 3.45 (m, 4H), 3.08-3.22
(m, 2H), 2.67 (m, 2H), 2.55 (m, 2H), 2.42-2.52 (m, 1H), 2.20 (t, 2H, J = 7.2 Hz), 1.861.96 (m, 1H), 1.59-1.78 (m, 4H), 1.40-1.55 (m, 2H). IR (neat): 3319, 3084, 2922, 2870,
1732, 1633, 1549, 1454, 1109 cm–1.
Synthesis of TA–PEG600–Biotin. TA–PEG600–NH2 (0.31g, ~4.0x10-4mol),

biotinyl-N-hydroxysuccinimide (0.15 g, ~4.4x10-4mol), and DMF (8.5 mL) were mixed
and purged with N2. Triethylamine (0.26 mL) was added dropwise and the reaction was
stirred for 18 h at room temperature. The solvent was evaporated under vacuum, and the
crude product was chromatographed on silica gel using a 10:1 (v/v) CH2Cl2:MeOH eluent
to obtain the product (~65 % yield). TLC (5:1 (v/v) CH2Cl2:MeOH) Rf = 0.62. 1H NMR
(400 MHz, CDCl3): δ 6.85–7.05 (m, 1H), 6.4–6.8 (m, 1H), 6.2–6.4 (m, 1H), 5.3–5.5 (m,
1H), 4.51 (m, 1H), 4.33 (m, 1H), 3.5–3.9 (m), 3.4–3.5 (m, 2H), 3.08–3.23 (m, 3H), 2.88–
2.96 (m, 1H), 2.75 (d, 1H, J = 12.8 Hz), 2.42–2.51 (m, 1H), 2.16–2.3 (m, 4H), 1.87–1.96
(m, 1H), 1.6–1.8 (m, 8H), 1.4–1.6 (m, 4H). IR (neat): 3295, 3083, 2928, 2865, 1707,
1645, 1550, 1461, 1108 cm–1.
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Synthesis of DHLA-PEG600-NH2. TA–PEG600–NH2 (0.58 g, 7.4x10-4 mol),

and ethanol (10 mL) was stirred under N2 and cooled to ~0 °C using an ice bath. NaBH4
(8.4x10-2 g, 2.2x10-3 mol) was dissolved in H2O (5 mL) and added dropwise into the
reaction. It was stirred for 2 h, warmed up to room temperature, and stirred overnight.
The ethanol was evaporated from the reaction mixture. The mixture was then diluted
with brine (10 mL) and extracted with CH2Cl2. The organic layers were dried over
Na2SO4 to obtain the product (~93 % yield), which was a colorless viscous oil at room
temperature. 1H NMR (400 MHz, in CDCl3): δ 6.35-6.45 (br s, 1H), 3.58-3.70 (m), 3.56
(t, 2H, J = 4.8 Hz), 3.51 (t, 2H, J = 4.8 Hz), 3.46 (m, 2H), 2.92 (m, 1H), 2.85 (t, 1H, J =
5.2 Hz), 2.62-2.78 (m, 2H), 2.20 (t, 2H, J = 7.6 Hz), 1.86-1.96 (m, 1H), 1.59-1.78 (m,
4H), 1.40-1.55 (m, 2H). IR (neat): 3196, 3061, 2866, 2509, 1662, 1543, 1456, 1099 cm–1.
Synthesis of DHLA-PEG600-COOH. TA–PEG600–COOH (1.75 g, 2.22x10-3

mol), ethanol (20 mL) and H2O (5 mL) was stirred under N2 and cooled to ~0 °C using an
ice bath. NaBH4 (0.35 g, 9.25x10-3 mol) was dissolved in H2O (7 mL) and added
dropwise into the reaction. It was stirred for 2 h, warmed up to room temperature, and
stirred overnight. The ethanol was evaporated from the reaction mixture, which was then
acidified to pH~2 using a 1 M HCl solution, and extracted with CH2Cl2. The organic
layers were dried over Na2SO4 and the solvent evaporated to obtain the desired product
(~95 % yield), which was a colorless viscous oil at room temperature. 1H NMR (400
MHz, in CDCl3): δ 6.75-6.95 (br s, 1H), 6.1-6.3 (br s, 1H), 3.58-3.70 (m), 3.54 (m, 4H),
3.45 (m, 4H), 2.92 (m, 1H), 2.62-2.79 (m, 4H), 2.55 (m, 2H), 2.20 (t, 2H, J = 7.4 Hz),
1.86-1.96 (m, 1H), 1.40-1.80 (m, 7H), 1.36 (t, 1H, J = 8.0 Hz), 1.31 (d, 1H, J = 7.6 Hz).
IR (neat): 3319, 3082, 2924, 2854, 2553, 1734, 1649, 1547, 1462, 1111 cm–1.
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6.2.2

Cap Exchange of QDs with Multifunctional Ligands

Cap exchange of the TOP/TOPO-capped CdSe/ZnS QDs with neat DHLAPEG600-FN ligands or a mixture of DHLA-PEG750-OCH3 and DHLA-PEG600-FN (i.e.
FN= -NH2 or -COOH) was carried out following the procedure described in Section
4.2.2.5,6 The major difference is the composition of the ligand used for the reaction. For

example, to prepare cap-exchanged QDs with 30% amine and 70% methoxy terminal
groups, the ligand mixture used is composed of the respective molar ratio of the two
ligands. The total amount of ligands used is ~50,000 time the amount of QDs being cap
exchange. A list of the calculated molecular weights of the ligands synthesized in this
dissertation is listed in Appendix B.

6.2.3

Gel Electrophoresis of Cap-exchanged QDs

Gel electrophoresis experiments were conducted using QDs that were capexchanged with either a homogenous (using one type of ligand), or a heterogeneous
surface cap (using mixtures of either DHLA-PEG-OCH3 and DHLA-PEG600-NH2 or
DHLA-PEG-OCH3 and DHLA-PEG600-COOH). The nanocrystal dispersions were run
on a 1 % agarose gel using tris borate EDTA buffer (TBE, 89mM tris borate, 2mM
EDTA) that was adjusted to pH 6.9 by adding dilute HCl (2 M). QD samples were
diluted to ~1-2 µM concentrations in a 10 % glycerol loading buffer immediately prior to
loading into the gel. The experiments were conducted using a voltage of 3-5 V/cm and
fluorescence images were captured using a Kodak 440 Digital Image Station.
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6.2.4

Conjugation of Functionalized QDs to Organic Dyes

Surface-modified and functionalized QDs were covalently attached to organic
fluorophores by using three common bioconjugation techniques: 1-ethyl-3-(3dimethylaminopropyl)-carbodiimide (EDC) coupling to carboxyl functionalized QDs as
well as succinimidyl ester and isothiocyanate coupling to amine functionalized QDs.4
The QDs used in the below reactions were dispersed in water at concentrations of 2-5 uM
and the volume of QD solution added was adjust appropriately.

EDC coupling: Carboxyl functionalized QDs (CdSe/ZnS, λem= 552 nm) were

conjugated to Lissamine rhodamine B ethylenediamine dye (L-RhdB, Invitrogen) via
EDC coupling. L-RhdB (1 mg) was first solubilized in 500 µL of dimethyl sulfoxide
(DMSO) and then 2.83 mL of PBS was added to the mixture to make a stock solution of
500 mM L-RhdB. Carboxyl functionalized QDs (400 pmol, 30 % carboxyl ligands) and
L-RhdB (0.1 µmol, 200 µL) were added to PBS (680 µL in total volume) in a 2.5 mL
micro-centrifuge tube (Eppendorf). Then freshly prepared EDC (80 µL of 1 M in PBS)
and N-hydroxysulfosuccinimide (sulfo-NHS, 80 µL of 50 mM in PBS) solutions were
added and mixed with the reaction mixture. The micro-centrifuge tube was wrapped in
aluminum foil and shaken for 45 mins. Then, more freshly prepared EDC and sulfo-NHS
(80 µL of each) was added and the solution was mixed again and shaken for an additional
75 mins. Once the reaction is complete (2 h total), the excess EDC, sulfo-NHS and
rhodamine dye was removed by size exclusion column chromatography (PD-10 desalting
columns, GE Healthcare) using PBS as the eluent. The purified QD-dye conjugates were
collected in 1 mL fractions. If additional purification was needed (i.e. there was poor
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separation between free dye and conjugates in the column), the combined fractions were
dried to 1 mL of solution using a vacuum centrifuge and the sample was
chromatographed again. Negative control reactions were also conducted by adding PBS
in the place of EDC and sulfo-NHS to reaction.

Succinimidyl ester coupling: Amine functionalized QDs were conjugated to

rhodamine via a succinimidyl ester functional group. A stock solution of Rhodamine Red
succinimidyl ester (RhdR-SE, Invitrogen) was prepared by dissolving ~0.7 mg of dye in
50 µL of DMSO and then diluting the mixture with sodium tetraborate buffer (pH 9.5, 1
mL). The concentration of the stock solution was confirmed by UV-vis absorption
spectroscopy prior to use. Amine functionalized QDs (400 pmol, 30 % amine ligands)
and RhdR-SE (0.1 µmol) were added to sodium tetraborate buffer (800 µL in total
volume) in a micro-centrifuge tube. The tube was then wrapped in aluminum foil and
shaken at 4 °C overnight (~18 h). Then the reaction was purified by size exclusion
chromatography (PD-10 columns, GE Healthcare) as described above.

Isothiocyanate Coupling: Amine functionalized QDs were conjugated to

fluorescein isothiocyanate (FITC, Sigma Aldrich). 60% amine functionalized QDs (500
pmol) and FITC (0.3 µmol) were mixed with sodium tetraborate buffer (pH 9.5, 1 mL) in
a microcentrifuge tube. The reaction mixture was wrapped in aluminum foil and shaken
at 4 °C overnight (~18 h). Then the reaction was purified by size exclusion
chromatography (PD-10 columns, GE Healthcare) as described above.
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6.3

Results and Discussion

6.3.1

Ligand Synthesis and Characterization

While the synthetic route (Figure 6.1) to obtain the multifunctional ligands
reported here follow the same rational as published by Susumu et al.,5 modifications were
necessary due to the use of a longer PEG chain, which changed the ligands’ solubility.
To synthesize the ligands listed above, the hydroxyl end groups of poly (ethylene glycol)
(MW ~600 Da) molecules were converted to azides by a two step reactions: first using
methane sulfonyl chloride followed by reacting with triethlyamine. Next, one of the
azide terminal groups were reduced to an amine using triphenylphosphine; this is the
step that required most alternation from reference 5. In order to increase the yield of N3PEG400- NH2, Susumu and coworkers conducted the reaction in a biphasic reaction
consisting of ether and phosphoric acid.5,7 The use of the same reaction condition for N3PEG600-NH2 resulted in low reaction yields (< 10%). As a result, a biphasic reaction
which consisted of ethyl acetate and HCl was instead.8 This is a critical improvement as
the syntheses of all the final compounds use N3-PEG600-NH2 as a precursor. Following
the production of N3-PEG600-NH2, thioctic acid (TA) was appended to the molecule by
dicyclohexylcarbodiimide (DCC) coupling to produce TA-PEG600-N3. After reduction
of the azide group on TA-PEG600-N3, TA-PEG600-NH2 was produced. TA-PEG600biotin and TA-PEG600-COOH were produced by appending biotin and carboxyl groups
to the amino-group, respectively. Before these ligands can be used for surface
modification of QDs, their thioctic acid rings were reduced with sodium borohydride
(NaBH4) (Figure 6.1, bottom). As the thioctic acid is attached to the PEG via an amide
bond, same as the DHLA-PEG-OCH3 ligand reported in Chapter 4, the reduction step can
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be performed using excess NaBH4 (up to 4 fold excess) without causing any
decomposition of the ligand.
In addition to the modification of the biphasic reaction of N3-PEG- NH2, we also
improved the purification of the compounds shown in Figure 6.1. These improvements
culminated in the increase of the reaction yield from ~50 % to values exceeding 70 % for
N3-PEG600-NH2 routinely. The purification of the compounds were improved by
utilizing liquid-liquid extractions to isolate the product. These details of each step are
provided in the Experimental section for each ligand as well as reported in reference 9;
they improved the efficiency of the synthetic route (i.e. higher yields in a shorter time).
All the ligands synthesized were characterized with TLC, FT-IR and 1H NMR, and the
data were essentially the same as reported in reference 5, indicating that the improved
synthetic steps provide the same final products (with the exception of having a longer
PEG segment as reflected in 1H NMR).

6.3.2

Tuning the Functional Group Density on Biocompatible QDs

Since QDs (and other nanoparticles) present large surface areas compared to
small molecules, their surface functionalization with molecular scale ligands and block
copolymers can produce high numbers of reactive functional groups per nanocrystal.
Controlling the density of those groups on the final nanocrystals’ surface is crucial, as it
allows one to tune the “reactivity” of the nanocrystals. To achieve this goal in the present
strategy, capping QDs with a desired DHLA-PEG-FN ligand is carried out using
mixtures with a second “inert” ligand (e.g., DHLA–PEG600–OH or DHLA–PEG600–
OCH3). The ability to tailor the surface is enabled by the modular design of the ligands;
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all the final compounds (Figure 6.2) have the same composition with the exception of the
terminal functional group. This allows the mixing of the ligands in a single cap exchange
step to produce nanoparticles with mixed surfaces of varying functional group density.5,10
With the DHLA-PEG600-FN ligands presented here, we can prepare water-soluble and
stable QDs with varying density of the functional group from 0% to 100%; capexchanged QDs with 100% -COOH or –NH2 were observed to be stable in water for at
least 6 months at the time of writing this document.
We demonstrated our control of the functional group density or the valency of the
QDs by performing gel electrophoresis QD dispersions capped with mixtures of either
DHLA-PEG-OCH3 and DHLA-PEG600-NH2 or DHLA-PEG-OCH3 and DHLAPEG600-COOH. Figure 6.3 shows a comparison of the mobility shift of 552-nm
emitting QDs cap-exchanged with different ligand compositions after 15 minutes of
electrophoresis: DHLA-PEG600-COOH:DHLA-PEG-OCH3 at molar fractions of
carboxyl groups between 5 % and 30 % (lanes 1-3); neat DHLA-PEG-OCH3 (lane 4);
and DHLA-PEG-OCH3:DHLA-PEG600-NH2 with molar fractions of amines between 5
% and 60 % (lanes 5-8). No QD migration was measured for nanocrystals capped with
neat DHLA-PEG750-OCH3 (lane 4), indicating that these QDs were essentially neutral.
In contrast, QDs having a small fraction of DHLA-PEG600-COOH ligand migrated
towards the positive electrode, while QDs surface-modified with a fraction of DHLAPEG600-NH2 ligand migrated towards the negative electrode, as anticipated from the
nature of the end groups. Furthermore, the mobility shift depended on the fraction of
charged ligands used for the cap exchange, with larger shifts measured for larger molar
ratios. The changes in mobility shifts measured for the various samples were consistent
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with the nature and percentage of the chargeable end functional units present at the end of
the ligands. This experiment shows that we can indeed achieve control over the density
of a specific function by mixing the corresponding ligand with the inert DHLA-PEG750OCH3, which provides the means to precisely control the fraction of added chemical
functionalities on the nanocrystal surface.

6.3.3

Conjugation of Functionalized QDs to Organic Dyes

One of the major goals of this work is to provide the research community
interested in using QDs with the means of achieving simple and reproducible conjugation
strategies that allow the preparation of robust and functional QDs and QD-bioconjugates.
With the ligands synthesized above, we demonstrate three conjugation techniques that are
ubiquitous in biology: 1) EDC coupling, 2) succinimidyl ester coupling and 3)
isothiocyanate coupling.
In a simple demonstration, we reacted QDs capped with a mixture of DHLA–
PEG600–OH and DHLA–PEG600–COOH (30% COOH) with L-RhdB in the presence of
EDC and sulfo-NHS in PBS buffer. Sulfo-NHS was added to the reaction to increase the
reaction yield since the EDC intermediate precursor is not stable (Figure 6.4).4,11 In
addition, due to the short half life of EDC in water (~30 mins in pH 7.4), it was added to
the aqueous reaction in two aliquots.11 No aggregation or precipitation buildup was
observed either during or after the coupling reaction. Following removal of excess
unreacted dyes and reagents from the reaction mixture by size exclusion chromatography,
the absorption spectrum of the QD-dye conjugates was measured (Figure 6.5). The
optical features for reactions carried out in the presence of EDC indicated significant
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contributions from the dye. In particular, there is a new strong absorption peak at 570
nm, which comes from the organic fluorophore, in addition to the contribution from the
QDs. In contrast, when the reaction was carried out without EDC (control experiment),
the first major fractions collected from the chromatography column contained only
unreacted QDs (green circles). The simple superposition of the QD and dye spectra in
the QD-dye conjugate suggests that the two components are indeed coupled together and
that the QD does not affect the dyes chemical structure and the dye does not alter the
surface passivation of the QD (a key requirement).
Coupling reactions between amine-functionalized QDs and succinimidyl ester as
well as isothiocyanate functionalized dyes were also carried out. The purification and
characterization procedures of the formed conjugates follow the same rationales, but
these coupling reactions have the added advantage of not requiring additional reagents,
unlike EDC. The reagents are also more stable and therefore the reactions were
incubated overnight. The reactions were conducted in sodium tetraborate buffer (pH
9.5), so the amines are expected to be deprotonated and therefore neutral in charge. In
the first demonstration, amine-functionalized QDs (30 % DHLA-PEG600-NH2, 70 %
DHLA-PEG600-OH) were conjugated to RhdR-SE (Figure 6.6). This reaction is
essentially the last step of the EDC reaction (Figure 6.4, Figure 6.6 inset), where the
succinimidyl reacts with the amine present on the QDs. Again, the absorption spectrum
of the QD-dye conjugates show a superposition of the QD and dye absorption features.
The second demonstration of amine-functionalized QD conjugation was done using FITC
and 60% amine (40% DHLA-PEG750-OCH3). The absorption spectra of the QD, dye
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and QD-dye conjugate (Figure 6.7) also show that the dyes were successfully conjugated
to the amine-functionalized QDs.
The promising conjugation examples shown here are done with common organic
fluorophores. However these techniques can be used to attach other biomolecules (i.e.
peptides, proteins, etc.). The QDs surface-modified with the ligands presented here
provides a versatile tool for biological applications.

6.3.4

Ligand Quantification Using Functionalize QDs

For QDs to be useful in biosensors and clinical diagnostic applications, it is often
necessary to quantify the number of surface ligands available on a QD after cap
exchange. Thus far, there have been some work reported in literature regarding the
number of surface ligands bound to a QD,10,12-16 but there are large discrepancies in the
results (3-300 ligands per QD of a similar size regime). The differences may be due to
the quantification methods used and the QD system studied (CdSe13, CdSe/ZnS10,12,16,
and InP15). While the number of surface ligands bound will determine the solubility and
stability of the QD, the number of available binding sites (i.e. exposed functional groups)
will be a major factor that determines the number of biomolecules that can be
accommodated on a surface-modified quantum dot.
We quantified the number of accessible functional groups per QD by preparing
nanoparticles with increasing fraction of carboxyl-terminated ligands, as confirmed by
gel electrophoresis (Figure 6.8). Then, we coupled a dye (L-RhdB) to the functionalized
nanoparticles via EDC coupling, and measured the absorption spectra of the QD-dye
complex after removing the excess dye and coupling reagents to obtain spectra similar to
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the one shown in Figure 6.5. The QD and dye concentration was determine by applying
the Beer-Lambert law, where the QD concentrations were determined according to the
size-dependent extinction coefficient as described in Section 2.3.6 17 and the dye
concentrations were determined using a measured extinction coefficient (102,000 M-1 cm-1,
L-RhdB in PBS). The ratio of dyes per QD bound increases with the number of carboxyl
groups presented on the surface of the QD as shown in Figure 6.9; the QDs shown in this
example are 552 nm emitting CdSe/ZnS core/shell nanoparticles ~6 nm in diameter. The
linear increase of dyes per QD becomes non-linear at high surface fraction of COOH
groups present; this may be attributed to a steric or electrostatic hindrance of the dyes.
From this data, we determined that the number of accessible carboxyl groups per QD can
be tuned between 0 to as high as ~50. Furthermore, by extrapolating the linear region of
the curve, we determined that there are approximately 65-70 ligands per QD. This value
is slightly lower than what the Bawendi group recently published (~140 amines for 100%
surface-modified QDs). The difference can be a result of a number of factors, the most
practically obvious being that it is a different batch of nanoparticles (produced in
different labs), which may have different surface characteristics. Another major
difference is that the Bawendi group10 used a fluorescamine assay,4 which does not
discriminate between surface-bound amines from free amines that are in solution. As a
result, the number of surface-bound ligands measure could be inflated by the signal
contribution from the free amines. Finally, the available methods for determining the
concentration of QDs is another source of error since it does not account for the
absorbance of the ZnS overcoating layer; the report by the Bawendi group relies on the
same method as we do for the QD concentration quantification.16,17 Nonetheless, this
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method gives the best available estimation of the number of ligands and accessible
functional groups presented on a nanoparticle surface. More importantly, this method is
relatively easy to implement and can be used to characterize the surface-modified QDs
prior to use if the “valency” of the QD is significant for the particular application. It can
also be applied to QDs with other functionality (i.e. amine, biotin, etc.) since there are
numerous functionalized organic dyes with established extinction coefficients (i.e.
fluorescein isothiocyanate can be used to determine the number of amines).

6.4

Conclusion

This chapter presents the synthesis and application of bifunctional surface ligands
that compose of an anchoring group (thioctic acid), a PEG segment of 600 MW and
various terminal groups. The ligands were used to surface modify QDs to provide QDs
of varying surface charge and functional group density. The surface-modified QDs were
then used in bioconjugation demonstrations that employed common coupling chemistries
like EDC, succinimidyl ester and isothiocyanate. These ligands provide a versatile means
of surface modifying QDs and tailoring their functional group density. The resulting
QDs enable the use of facile conjugation techniques to covalently attach biomolecules to
the nanoparticles for sensing and imaging applications. Furthermore, we present a
method of determining the number of accessible functional groups on these surfacemodified QDs. Using the technique, we estimated approximately 65-70 ligands per QD
and ~50 available carboxyl groups for bioconjugation.
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Figure 6.1. Chemical structures and synthetic routes of bifunctional surface ligands used
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synthesized and used in this work (top).5 Since the ligands are essentially the same (aside
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Figure 6.3: Images of gel electrophoresis of QDs capped with different surface ligands.
(1) 30 % COOH : 70 % OCH3, (2) 15 % COOH : 85 % OCH3, (3) 5 % COOH : 95 %
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Figure 6.6: Absorption spectra of 30 % amine functionalized CdSe/ZnS (green, solid
line), Texas Red succinimidyl ester dye (maroon, dashed line), and QD-Dye conjugate
(black, solid line). The inset of the figure shows the coupling reaction schematic of
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line), fluorescein isothiocyanate dye (maroon, dashed line) and QD-Dye conjugated
(black, solid line). The inset of the figure shows the coupling reaction schematic of
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CHAPTER 7

FRET-BASED BIONSENSOR TO DETECT THE ACTIVITY OF
THE INNATE IMMUNE SYSTEM

7.1

Introduction to FRET and Toll-like Receptor (TLR) Proteins

Förster (fluorescence) resonance energy transfer (FRET) is a phenomenon that
occurs when a donor fluorophore transfers its energy to a neighboring acceptor
fluorophore in a non-radiative way. As a result, the donor emission will be attenuated
and the acceptor emission will be enhanced. This phenomenon occurs only when the
emission of the donor is spectrally overlapped with the acceptor’s absorption, as
illustrated in Figure 7.1, and the two fluorophores are sufficiently close (< ca. 10 nm).
Since the energy transfer is done via dipole-dipole interaction, the operating distance
between the donor and acceptor is much smaller (approximately an order of magnitude
smaller) than the radiative energy transfer described in Chapter 3. QDs are ideal donors
in FRET-based systems as their emission wavelength can be easily tuned, by changing
the particle size, to optimize the spectral overlap between the QD emission and the
acceptor absorption while maintaining a good separation between the QD (donor) and the
acceptor emission (Figure 7.1). 1
The efficiency of the energy transfer is determined by the following equations2:
e−n n k
kR0
, E(k) =
E (n ) = ∑ p(n,k)E (k ) , with p(n,k) =
6
k!
kR0 + r 6
k=1
6

n

(7.1)

where r is the center-to-center separation distance for all dyes in these centro-symmetric
conjugates, while n and k designate the nominal average and exact number of acceptors
per QD-conjugate, respectively; k varies between 0 and n.3,4 Note that the FRET
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formalism presented in Equation (7.1) accounts for a Poisson distribution of the number
of acceptors per donor (QD) as demonstrated by Pons et al.4,5 R0 is the Förster radius,
which is defined as the distance at which the efficiency of the energy transfer is reduced
to 50%. R0 is defined as:

R 0 = 978 × ( Q D κ 2 n r −4 J D A ) 1 / 6

(7.2)

where QD is the donor quantum yield, nr is the index refraction of the medium, κ2 is the
orientation factor (2/3 for dynamic averaging for isotropic transition moments), and JDA is
the overlap integral, which is defined as:
∞

J DA = ∫ f D ( λ ) ε A ( λ ) λ4 d λ
0

(7.3)

where fD(λ) is the normalized fluorescence spectrum of the donor dye, and εA is the
absorption spectrum expressed as its extinction coefficient.
FRET-based biosensors have been demonstrated for the purposed of detecting the
presence of solution TNT as well as determining the proteolytic activity of enzymes.3,6-8
In this section, we discuss a proof-of-concept to of a FRET-based biosensor to detect the
activity of the innate immune system via Toll-Like receptors (TLR’s), which are a family
of proteins that are part of the body’s immune system.
The immune system is a collection of mechanisms that protect our bodies from
invaders such as viruses and bacteria. Our body’s defense can be broken down into two
distinct layers: the innate and adaptive immune systems. The innate immune system is
our first line of defense, which relies on a non-specific recognition mechanism to detect
foreign bodies. It responds to pathogens in a generic way and does not have a “memory”
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(i.e. does not provide long lasting immunity) unlike the adaptive immune system. If
necessary, the innate immune system triggers the adaptive immune system, which adapts
its response during an infection to detect pathogens.
TLRs are a class of membrane-spanning proteins that initiate the host’s response,
and is believed to play a key role in the innate immune system.9,10 Using pattern
recognition, they identify molecules that are broadly shared by pathogens but
distinguishable from host molecules.11 These proteins reside on the membranes of cells
or the cells’ organelles as illustrated in Figure 7.2. There are 15 different identified TLR
proteins, each recognizing different microbial targets (some TLR targets have not yet
been identified). The protein that will be studied here is TLR9, which recognizes and
binds microbial (unmethylated) DNA.12 The proteins used in this study are
bioengineered by the Research Group of Professor Eicke Latz (UMass Medical School)
to consist of a 6-histidine (His6) sequence, an ectodomain (sensing segment), and a
crystallizable (Fc) fragment region (His6-TLR9-Fc). The ectodomain of the TLR protein
binds strongly to its target (unmethylated CpG DNA for TLR9), and the histidine tag can
assemble onto the surface of the CdSe/ZnS core/shell QDs via strong metal-affinity
coordination with Zn2+ on the QDs.6,13 The focus of this work is to demonstrate a FRET
biosensor using TLR9 to detect the presence of CpG DNA.

7.2

Experimental Methods and Procedures

Here we describe the assembly of TLRs to the surface of DHLA-QDs and we
demonstrate the use of the QD-bioconjugate in a FRET biosensing scheme.
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7.2.1

Histidine Tagged TLR Binding to DHLA-QDs

His6-TLR9-Fc proteins were mixed with DHLA-QDs (protein to QD ratios
varying from 0 – 4) in 10 mM sodium tetraborate buffer (pH=9.5, 15 µL total volume)
and allowed to react for 30 minutes (Table 7.1). Following the protein binding reaction
(~20 minutes), gel electrophoresis was conducted on the reaction mixtures. The
experiments were conducted with an applied current of ~80mAmps in a tris borate EDTA
(TBE, 89 mM tris borate, 2 mM EDTA) buffer. Since the proteins were so large (320
kDa as functional dimer), 0.7% and 1.0% agarose gels were utilized. The gels were
photographed by illuminating them with a UV lamp and using a long pass filter to only
show the emission of the QDs using a Kodak 440 Digital Image Station.

Table 7.1a: Mixing composition of TLR9 titration of DHLA-QDs: 0-4 TLR9 per QD
TLR9 : QD
QDs (5µM)
TLR9 (3 µM), µL
6x Loading Buffer
NaTetBorate, µL

0
0
10

1

2
4
2µL (10 pmol)
3.3
6.7
1.3
3 µL
6.7
3.3
8.7

0
0
10

Table 7.1b: Mixing composition of TLR9 titration of DHLA-QDs: 0-1 TLR9 per QD
TLR9 : QD
QDs (5µM)
TLR9 (3 µM), µL
6x Loading Buffer
NaTetBorate, µL

7.2.2

0

0.1

0

0.33

10

9.67

0.25

0.5
0.75
2µL (10 pmol)
0.83
1.65
2.48
3 µL
9.17
8.35
7.52

1

0

3.3

0

6.7

10

Detection of Binding Target Using TLR-QD Complexes

FRET experiments were conducted using 552 nm emitting CdSe/ZnS QDs
(capped with DHLA) as the donor and Texas Red labeled CpG DNA (TR-CpG) as the
acceptor and histidine appended TLR9 as the linker between the two (Figure 7.3). His6TLR9-Fc proteins were first mixed with TR-CpG, then the TR-CpG bound TLR9 were
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mixed with DHLA-QDs. The TR-CpG were mixed with TLR9 at different ratios as
indicated in Table 7.2 (Top), and allowed to react for 30 minutes in 10 mM sodium
tetraborate buffer (pH 9.5). Then QDs were added to the reaction mixture at the mixing
ratio of 1.5 proteins to QD (Table 7.2 Bottom). The QDs were allowed to react with the
TLR9 bound TR-CpG for 30 minutes, and then the photoluminescence (PL) of the
reaction mixtures was measured using a Tecan microplate reader. Control experiments
were also conducted, where the volume of TLR9 was replaced with buffer.

Table 7.2: Mixing composition of TR-CpG titration of TLR9 (top) and FRET experiment
with the addition of DHLA-QDs (bottom).
Sample #
TLR9 (3 µM), µL

1

TR-CpG

0

NaTetBorate, µL

22.7

QD (2 µM), µL
TR-CpG: QD

0

2

3

4
5
6
7
7.3 µL (22 pmol)
1.5 µL
3.0 µL
6 µL
12 µL
1.8 µL
2.3 µL
(10 µM) (10 µM) (10 µM) (10 µM) (100µM) (100µM)
20.6
19.1
16.1
10.7
20.9
20.4
1

2

75 µL ( 15 pmol)
4
8

7.3

Results and Discussion:

7.3.1

The Design of FRET-biosensor Using TLR

12

15

The concept of the FRET-based biosensor is illustrated in Figure 7.3. The
binding target of the TLR (the antagonist) is conjugated with an acceptor dye (Texas
Red) and the TLR is bound to the QDs. If the dye-conjugated targets are mixed with the
TLR-QD complex in solution, the antagonist will be bound to the TLR, bringing the
acceptor dye close to the QD as shown in Figure 7.3 (left). If the acceptor dye (bound to
the antagonist) is close enough to the QD donor, then FRET will occur, resulting in a
measurable response. If the dye-labeled targets are mixed with a clinical sample
containing targets and added to TLR-QD complexes, the unlabeled targets (from the
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clinical sample) will compete for the binding site on the TLR, reducing FRET (i.e. the
fluorescence spectra will show a higher QD contribution and lower acceptor dye
component) as shown in Figure 7.3 (right). Using this scheme, a biosensor can be
developed to detect the presence and concentration of TLR targets in a patient’s blood for
example. It can also be used to detect the activity of TLRs triggered by certain biological
agents for example to better understand autoimmune diseases or as a drug screening tool.
Furthermore, this scheme can be expanded to include multiple targets (i.e. multiple TLRs,
which recognize different antagonists).14

7.3.2

Histidine Tagged TLR binding to DHLA-QDs

In order to explore the potential of developing a FRET-based biosensor with QDs
and TLR’s, we first need to confirm whether the His6 sequence on the protein was able to
attach onto the surface of the QDs. For these experiments, we used DHLA capped QDs
rather than DHLA-PEG functionalized QDs. The reasoning for this is because histidine
binding of large proteins to QDs capped with DHLA-PEG1000-OH is significantly lower
than DHLA capped nanocrystals as shown by Sapsford et al.15 The reduction of binding
of histidine-conjugated proteins to the surface of DHLA-PEG1000-OH-QDs is attributed
to steric hindrance since the histidine sequence (attached to the protein) is unable to
penetrate the organic layer to bind to the inorganic surface of the nanoparticle. We were,
however, able to bind to His-tagged peptides to DHLA-PEG-QDs since the peptide is
smaller enough to by-pass the organic layer.15,16 Since the TLR9 are fairly large (~160
kDa as monomers, or 320 kDa as dimers) we used DHLA-QDs for all the experiments to
avoid the issue of steric hindrance.
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In order to test whether we can assemble the TLR’s onto the surface of the QDs,
TLR9 proteins were mixed with QDs at increasing ratios from 0-4 proteins per QD.
After the conjugation reaction, gel electrophoresis of the reaction mixture showed only
one distinct band, which is that of unconjugated QDs. The remainder of the sample
appears as a streak following the major band, or was retained in the well of the gel. A
majority of the samples that contained more than 0.5 proteins per QD did not penetrate
the gel (retained in the well), presumably due to binding by the large proteins (Figure
7.4). Experiments conducted using 0.7% and 1.0% agarose gel showed the same result.
Furthermore, mixing ratios of 4 proteins per QD resulted in aggregation. These
experiments suggest that the proteins were able to bind to the QDs, and were bound so
tightly that the QDs were retained in the wells, instead of migrating toward the positive
electrode; the DHLA-QDs are negatively charge and would have migrated toward the
positive electrode (if unhampered) as shown by the control experiments in the first and
last lane of the two experiments. However, this is only indirect proof, and this hypothesis
needs addition confirmation.

7.3.3

Detection of Binding Target Using TLR-QD complexes

FRET experiments were conducted with the TLR9 protein by first binding TRCpG to TLR9 (in varying ratio of TR-CpG to TLR9), and the TR-CpG bound TLR9 were
mixed with DHLA-QDs. Following the assembly reactions, the emission spectra of the
samples were measured in a microplate fluorometer using an excitation radiation of 300
nm in wavelength (Figure 7.5); the QDs strongly absorb at 300 nm while the Texas Red
dye does not (Figure 7.1). As the number of TR-CpG increased in comparison to QD

147

(the amount of QD and TLR9 remained constant), the emission peak from Texas Red
(615 nm) also increased, as expected, due to the increase in the concentration of dye
(Figure 7.5). However, with increasing ratios of TR-CpG:QD, the emission intensity
from the QDs (552 nm) decreased, thus providing a proof of principle for FRET between
the QDs and TR. While this data suggests energy transfer, it is also possible that the
energy transfer is only due to proximal dyes that are not attached to the TLR9 protein. In
order to prove that the photoluminescence intensity decrease shown in Figure 7.5 was
indeed due to FRET from QDs bound to TR-CpG via the TLR-bridge, rather than by a
random distribution of the dyes close to the QD in solution, control experiments were
conducted in parallel. The PL spectra from the control experiments (varying TR-CpG
concentration in the presence of QDs and no TLR9) are shown in Figure 7.6.
Comparing the data shown in Figures 7.5 and 7.6, it can be seen that without the
presence of TLR9, the PL emission from the QDs did not decreased with increasing TRCpG. This suggests that the energy transfer shown in Figure 7.5, which is more than
solution phase energy transfer without TLR9 (Figure 7.6), is due to the presence of TLR9
that links the QDs to the TR-DNA complex. Calculations using the equations (7.2) and
(7.3) showed that the Forster radius, R0, of the FRET system was ~4.5 nm. Furthermore,

fitting the experimental data shown in Figure 7.5 to Equations (4.1), we were able to
extract that the Texas Red dyes were approximately located at an average distance of
~7.9 nm from the center of the QD-protein bioconjugate. Since the nanoparticles are
approximately 6 nm in diameter, the organic fluorophores are located ~4-5 nm from the
surface of the nanoparticle. This is in reasonable agreement given the size of the protein
(M.W. ~320 kDa as a dimer). The data suggests that there is potential to further develop
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this system into a TLR-based biosensor. TLR9 that was bound to its target (TR-CpG)
was successfully attached to the surface of the nanoparticle via the His6 sequence and the
increase in TR-CpG concentration was detectable using FRET.

7.4

Conclusion

In this chapter, we demonstrated a proof-of-concept of a FRET biosensor to detect
the presence of unmethlylated microbial DNA by using TLR9. We proved via gel
electrophoresis that His6-TLR9 was able to bind to the DHLA-QDs. While the gel
electrophoresis experiments provided indirect evidence of the formation of proteinnanoparticle conjugates, the ability of the TLR9 to bind to the QDs was demonstrated by
FRET experiments. Furthermore, we were able to show that the His6 sequence able to
bind to the nanoparticle surface even after the TLR9 has bound its target, the
unmethlylated CpG DNA. Results showed that energy transfer was measured when TRCpG bound TLR9 assemble onto QDs, while FRET was not measured without the TLR9
serving as a linker between the QD and the TR-CpG. The experimental results outlined
here demonstrate the potential to develop a TLR-based biosensor, as shown in Figure 7.3,
but more research is necessary in order to make it a reality. This technique offers a
platform that can be expanded to different TLRs and can even be multiplexed as shown
in reference 14.

Acknowledgements: I thank Professor Eicke Latz and Dr. Gabor Horvath from the

UMass Medical School in Worcester for providing the TLR9 and CpG DNA used in this
study and for their helpful and stimulating discussions.
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Figure 7.1: Normalized QD (donor) emission, Texas Red dye (acceptor) absorption and
emission spectra. The three spectra illustrate a good spectral overlap between the donor
emission and acceptor absorption, while maintaining good spectra separation between the
QD and dye emission spectra.
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Figure 7.2: Schematic of a Toll-like receptor that traverses the cell membrane, which
allows it to detect the extracellular environment and signal into the cytoplasm.9 Some
TLR’s reside on other cellular -organelle membranes (e.g. TLR9).

Figure 7.3: Schematic of FRET-based biosensor using TLR’s and QDs. Left: in the
presence of only dye-conjugated targets. Right: in the presence of dye-conjugated targets
and natural targets in clinical sample.
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Figure 7.5: PL emission (λEx=300nm) of FRET experiment where TR-DNA
complexes were bound to TRL9 at different ratios, then mixed with QDs at a ratio of
1.5 TLR per QD.
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APPENDIX A
MATERIALS AND INSTRUMENTATION
Reagents

•

Inert gas (N2 or Ar)

•

Trioctylphosphine (TOP, 90-95%, Acros Organics)

•

Trioctylphosphine oxide (TOPO, Acros Organics)

•

Hexadecylamine (HDA, Sigma Aldrich)

•

Selenium powder (-100 mesh, 99.99%, Sigma Aldrich)

•

Diethylzinc (ZnEt2, 1 M solution in heptane, Acros Organics)

•

Bis(trimethylsilyl)sulfide ((TMS)2S)

•

Cadmium acetylacetonate (Cd(acac)2)

•

Solvents: (hexane, butanol, methanol, ethanol, tetrahydrofuran (THF), chloroform
(CHCl3), methylene chloride (CH2Cl2), ether, ethyl acetate, acetone, N,Ndimethylformamide (DMF)
*THF was dried over aluminum oxide, and the CH2Cl2 was filtered through silica gel
to remove rust that probably originates from its metal container. All other solvents
were used as received without further purification.

•

Poly(ethylene glycol) (avg. MW ~600 Da; Acros Organics)

•

Poly(ethylene glycol) methyl ether (avg. MW ~550 and 750 Da; Sigma Aldrich)

•

Methanesulfonyl chloride (GFS Chemicals)

•

Triethylamine (Sigma Aldrich)

•

Deionized water

•

Sodium bicarbonate (NaHCO3; Acros Organics)

•

Sodium azide (NaN3; Alfa Aesar)

•

Sodium sulfate (Na2SO4, Sigma Aldrich)

•

Magnesium sulfate (MgSO4, Sigma Aldrich)

•

Deuterated chloroform (CDCl3) with 0.03 % TMS (Cambridge Isotope Laboratories,
Inc.)
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•

Deuterated dimethylsulfoxide (DMSO-d6, Acros Organics)

•

Phosphoric acid (H3PO4, Sigma Aldrich)

•

Triphenylphosphine (PPh3; Acros Organics)

•

Potassium hydroxide (KOH; Acros Organics)

•

Thioctic acid (TA, Acros Organics)

•

4-(N,N-Dimethylamino)pyridine (DMAP, Acros Organics)

•

N,N’-Dicyclohexylcarbodiimide (DCC, Acros Organics)

•

Sodium borohydride (NaBH4; Strem Chemicals)

•

Potassium tert-butoxide (Sigma Aldrich)

•

Hydrochloric acid (HCl, Fisher Scientific)

•

Celite (Sigma Aldrich)

•

Silica gel (60 Å, 230–400 mesh, Bodman Industries)

•

Phosphate buffered saline (PBS; 0.138M NaCl and 0.0027M KCl, Sigma-Aldrich)

•

Sodium tetraborate buffer (10 mM, pH = 9.5, Sigma-Aldrich)

•

COS-1 cell lines (ATCC, Manassas, VA)

•

Sodium bicarbonate buffer (pH 8.5)

•

Low-EEO agarose gel (Fisher Scientific)

•

Tris borate EDTA buffer (10x, Fisher Scientific)

•

Acetonitrile (HPLC grade, Sigma-Aldrich)

•

Citrate stabilized AuNPs (5, 10, 15 nm in diameter, Ted Pella, Inc., Reading, CA)

•

Sodium hydroxide (NaOH, Sigma Aldrich)

•

Oligonucleotide purification cartridges (OPC, Applied Biosystems, Foster City, CA).

•

Triethylamine acetate buffer (TEAA, 2 M, Applied Biosystems, Foster City, CA)

•

Lissamine Rhodamine B Sulfonyl Chloride (Invitrogen)

•

Rhodamine Red succinimidyl ester *5-isomer* (Invitrogen)

•

Toll-like receptor (His6-TLR9-Fc, Latz Group at Umass Medical School)

•

Unmethylated DNA labeled with Texas red dye (Latz Group, Umass Medical School)
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Equipment and instrumentation

•

Round-bottom flasks, one- and two-necked

•

Addition funnels

•

Keck clips

•

Magnetic stirring bars

•

Rubber septa

•

Hotplate magnetic stirrer

•

Thermometers

•

Distilling head

•

Glass syringes and needles

•

Plastic syringes and needles

•

Separatory funnels

•

Filter paper (Whatman qualitative circles)

•

Funnels

•

Rotary evaporator

•

Chromatography columns (glass)

•

Thin layer column chromatography (TLC) plates (silica gel matrix with aluminum
support, Sigma-Aldrich)

•

Iodine chamber to stain samples on TLC

•

pH test papers

•

Glovebox (MBraun Labmaster 130, Stratham, NH)

•

Schlenk line with nitrogen source

•

NMR (Bruker SpectroSpin 400 MHz spectrometer)

•

UV-Visible Spectrophotometer (HP 8453, Agilent technologies)

•

Fluorometer (Spex Fluorolog-3, Jobin Yvon Inc.)

•

Quartz cuvettes

•

Millex-LCR filter (Millipore, 0.45 µm pore size, hydrophilic PTFE, 25 mm diameter,
non-sterile)

•

Amicon Ultra-15 centrifugal filter unit with Ultracel-50 membrane (Millipore, MW
cut off ~50 kDa)

•

Centrifuges (IEC Centra CL2 centrifuge, Thermo Scientific)
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•

Eppendorf tubes (1.5 ml, Eppendorf International)

•

PD-10 desalting gel columns (GE Healthcare)

•

Digital image station gel reader (Kodak 440)

•

Vortexer

•

Micromanipulator system (InjectMan® NI2 equipped with a FemtoJet Programmable
Microinjector, Eppendorf, Westbury, NY)

•

Olympus IX-70 microscope (Center Valley, PA) equipped with a 500 nm long-pass
filter (Chroma Technology, Rockingham, VT) and a DP71 color digital camera
(Olympus, Center Valley, PA).

•

Safire Dual Monochromator Multifunction Microwell Plate Reader (Tecan Group
Ltd.)

•

Low background non-binding microtiter 96-well plate (Corning)

•

Continuum Infrared Microscope (Thermo Nicolet)

•

HP 8453 diode array spectrophotometer (Agilent technologies, Santa Clara, CA)

•

SPEX Flurolog-2 Spectrofluoroometer (Jobin Yvon Inc., Edison, NJ)

•

SpectraMax Gemini XS Microplate Spectrofluorometer (Molecular Devices
Corporation, Sunnyvale, CA)
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APPENDIX B
MOLECULES SYNTHESIZED
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